Cover
Cover - shares | 9 Months Ended | |
Jan. 31, 2024 | Feb. 27, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jan. 31, 2024 | |
Document Transition Report | false | |
Entity File Number | 001-37784 | |
Entity Registrant Name | GMS INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 46-2931287 | |
Entity Address, Address Line One | 100 Crescent Centre Parkway | |
Entity Address, Address Line Two | Suite 800 | |
Entity Address, City or Town | Tucker | |
Entity Address, State or Province | GA | |
Entity Address, Postal Zip Code | 30084 | |
City Area Code | (800) | |
Local Phone Number | 392-4619 | |
Title of 12(b) Security | Common Stock, par value $0.01 per share | |
Trading Symbol | GMS | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 39,833,628 | |
Entity Central Index Key | 0001600438 | |
Current Fiscal Year End Date | --04-30 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 88,341 | $ 164,745 |
Trade accounts and notes receivable, net of allowances of $15,548 and $13,636, respectively | 794,721 | 792,232 |
Inventories, net | 582,613 | 575,495 |
Prepaid expenses and other current assets | 35,239 | 17,051 |
Total current assets | 1,500,914 | 1,549,523 |
Property and equipment, net of accumulated depreciation of $295,789 and $264,650, respectively | 437,386 | 396,419 |
Operating lease right-of-use assets | 192,358 | 189,351 |
Goodwill | 723,025 | 700,813 |
Intangible assets, net | 382,614 | 399,660 |
Deferred income taxes | 23,103 | 19,839 |
Other assets | 12,153 | 11,403 |
Total assets | 3,271,553 | 3,267,008 |
Current liabilities: | ||
Accounts payable | 323,263 | 377,003 |
Accrued compensation and employee benefits | 98,447 | 119,887 |
Other accrued expenses and current liabilities | 106,643 | 107,675 |
Current portion of long-term debt | 48,094 | 54,035 |
Current portion of operating lease liabilities | 47,915 | 47,681 |
Total current liabilities | 624,362 | 706,281 |
Non-current liabilities: | ||
Long-term debt | 982,667 | 1,044,642 |
Long-term operating lease liabilities | 146,128 | 141,786 |
Deferred income taxes, net | 55,261 | 51,223 |
Other liabilities | 44,191 | 48,319 |
Total liabilities | 1,852,609 | 1,992,251 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Common stock, par value $0.01 per share, 500,000 shares authorized; 39,881 and 40,971 shares issued and outstanding as of January 31, 2024 and April 30, 2023, respectively | 398 | 410 |
Preferred stock, par value $0.01 per share, 50,000 shares authorized; 0 shares issued and outstanding as of January 31, 2024 and April 30, 2023 | 0 | 0 |
Additional paid-in capital | 345,818 | 428,508 |
Retained earnings | 1,100,660 | 880,968 |
Accumulated other comprehensive loss | (27,932) | (35,129) |
Total stockholders' equity | 1,418,944 | 1,274,757 |
Total liabilities and stockholders' equity | $ 3,271,553 | $ 3,267,008 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Statement of Financial Position [Abstract] | ||
Trade accounts and notes receivable, allowances (in dollars) | $ 15,548 | $ 13,636 |
Property and equipment, accumulated depreciation (in dollars) | $ 295,789 | $ 264,650 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 39,881,000 | 40,971,000 |
Common stock, shares outstanding (in shares) | 39,881,000 | 40,971,000 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 50,000,000 | 50,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | |
Income Statement [Abstract] | ||||
Net sales | $ 1,258,348 | $ 1,234,618 | $ 4,088,878 | $ 4,025,150 |
Cost of sales (exclusive of depreciation and amortization shown separately below) | 843,628 | 832,370 | 2,764,975 | 2,723,681 |
Gross profit | 414,720 | 402,248 | 1,323,903 | 1,301,469 |
Operating expenses: | ||||
Selling, general and administrative | 295,691 | 267,380 | 883,381 | 814,063 |
Depreciation and amortization | 32,804 | 31,419 | 97,759 | 96,085 |
Total operating expenses | 328,495 | 298,799 | 981,140 | 910,148 |
Operating income | 86,225 | 103,449 | 342,763 | 391,321 |
Other (expense) income: | ||||
Interest expense | (18,784) | (16,943) | (56,440) | (47,659) |
Write-off of debt discount and deferred financing fees | 0 | 0 | (1,401) | 0 |
Other income, net | 1,932 | 1,966 | 6,177 | 5,458 |
Total other expense, net | (16,852) | (14,977) | (51,664) | (42,201) |
Income before taxes | 69,373 | 88,472 | 291,099 | 349,120 |
Provision for income taxes | 17,468 | 23,697 | 71,407 | 91,722 |
Net income | $ 51,905 | $ 64,775 | $ 219,692 | $ 257,398 |
Weighted average common shares outstanding: | ||||
Basic (in shares) | 39,864 | 41,578 | 40,360 | 42,119 |
Diluted (in shares) | 40,512 | 42,232 | 41,026 | 42,812 |
Net income per common share: | ||||
Basic (in dollars per share) | $ 1.30 | $ 1.56 | $ 5.44 | $ 6.11 |
Diluted (in dollars per share) | $ 1.28 | $ 1.53 | $ 5.35 | $ 6.01 |
Comprehensive income | ||||
Net income | $ 51,905 | $ 64,775 | $ 219,692 | $ 257,398 |
Foreign currency translation adjustments | 14,404 | 10,215 | 4,638 | (21,728) |
Changes in other comprehensive income, net of tax | (7,044) | (1,880) | 2,559 | 1,469 |
Comprehensive income | $ 59,265 | $ 73,110 | $ 226,889 | $ 237,139 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Loss |
Beginning balance (in shares) at Apr. 30, 2022 | 42,773 | ||||
Beginning balance at Apr. 30, 2022 | $ 1,064,498 | $ 428 | $ 522,136 | $ 547,977 | $ (6,043) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 89,470 | 89,470 | |||
Foreign currency translation adjustments | 2,642 | 2,642 | |||
Other comprehensive income (loss), net of tax | 2,219 | 2,219 | |||
Repurchase and retirement of common stock (in shares) | (516) | ||||
Repurchase and retirement of common stock | (23,795) | $ (5) | (23,790) | ||
Equity-based compensation | 3,132 | 3,132 | |||
Exercise of stock options (in shares) | 1 | ||||
Exercise of stock options | 29 | 29 | |||
Vesting of restricted stock units (in shares) | 7 | ||||
Tax withholding related to net share settlements of equity awards | (300) | (300) | |||
Issuance of common stock pursuant to employee stock purchase plan (in shares) | 33 | ||||
Issuance of common stock pursuant to employee stock purchase plan | 1,329 | 1,329 | |||
Ending balance (in shares) at Jul. 31, 2022 | 42,298 | ||||
Ending balance at Jul. 31, 2022 | 1,139,224 | $ 423 | 502,536 | 637,447 | (1,182) |
Beginning balance (in shares) at Apr. 30, 2022 | 42,773 | ||||
Beginning balance at Apr. 30, 2022 | 1,064,498 | $ 428 | 522,136 | 547,977 | (6,043) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 257,398 | ||||
Foreign currency translation adjustments | (21,728) | ||||
Other comprehensive income (loss), net of tax | $ 1,469 | ||||
Repurchase and retirement of common stock (in shares) | (1,773) | ||||
Repurchase and retirement of common stock | $ (82,767) | ||||
Ending balance (in shares) at Jan. 31, 2023 | 41,347 | ||||
Ending balance at Jan. 31, 2023 | 1,230,696 | $ 413 | 451,210 | 805,375 | (26,302) |
Beginning balance (in shares) at Jul. 31, 2022 | 42,298 | ||||
Beginning balance at Jul. 31, 2022 | 1,139,224 | $ 423 | 502,536 | 637,447 | (1,182) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 103,153 | 103,153 | |||
Foreign currency translation adjustments | (34,585) | (34,585) | |||
Other comprehensive income (loss), net of tax | 1,130 | 1,130 | |||
Repurchase and retirement of common stock (in shares) | (601) | ||||
Repurchase and retirement of common stock | (25,776) | $ (6) | (25,770) | ||
Equity-based compensation | 3,781 | 3,781 | |||
Exercise of stock options (in shares) | 53 | ||||
Exercise of stock options | 672 | 672 | |||
Vesting of restricted stock units (in shares) | 101 | ||||
Vesting of restricted stock units | 0 | $ 1 | (1) | ||
Tax withholding related to net share settlements of equity awards | (3,660) | (3,660) | |||
Ending balance (in shares) at Oct. 31, 2022 | 41,851 | ||||
Ending balance at Oct. 31, 2022 | 1,183,939 | $ 418 | 477,558 | 740,600 | (34,637) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 64,775 | 64,775 | |||
Foreign currency translation adjustments | 10,215 | 10,215 | |||
Other comprehensive income (loss), net of tax | (1,880) | (1,880) | |||
Repurchase and retirement of common stock (in shares) | (656) | ||||
Repurchase and retirement of common stock | (33,196) | $ (6) | (33,190) | ||
Equity-based compensation | 3,285 | 3,285 | |||
Exercise of stock options (in shares) | 104 | ||||
Exercise of stock options | 1,729 | $ 1 | 1,728 | ||
Vesting of restricted stock units (in shares) | 2 | ||||
Tax withholding related to net share settlements of equity awards | (45) | (45) | |||
Issuance of common stock pursuant to employee stock purchase plan (in shares) | 46 | ||||
Issuance of common stock pursuant to employee stock purchase plan | 1,874 | 1,874 | |||
Ending balance (in shares) at Jan. 31, 2023 | 41,347 | ||||
Ending balance at Jan. 31, 2023 | $ 1,230,696 | $ 413 | 451,210 | 805,375 | (26,302) |
Beginning balance (in shares) at Apr. 30, 2023 | 40,971 | 40,971 | |||
Beginning balance at Apr. 30, 2023 | $ 1,274,757 | $ 410 | 428,508 | 880,968 | (35,129) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 86,830 | 86,830 | |||
Foreign currency translation adjustments | 11,398 | 11,398 | |||
Other comprehensive income (loss), net of tax | 5,389 | 5,389 | |||
Repurchase and retirement of common stock (in shares) | (469) | ||||
Repurchase and retirement of common stock | (30,784) | $ (5) | (30,779) | ||
Equity-based compensation | 3,304 | 3,304 | |||
Exercise of stock options (in shares) | 46 | ||||
Exercise of stock options | 1,248 | 1,248 | |||
Issuance of common stock pursuant to employee stock purchase plan (in shares) | 58 | ||||
Issuance of common stock pursuant to employee stock purchase plan | 2,664 | $ 1 | 2,663 | ||
Ending balance (in shares) at Jul. 31, 2023 | 40,606 | ||||
Ending balance at Jul. 31, 2023 | $ 1,354,806 | $ 406 | 404,944 | 967,798 | (18,342) |
Beginning balance (in shares) at Apr. 30, 2023 | 40,971 | 40,971 | |||
Beginning balance at Apr. 30, 2023 | $ 1,274,757 | $ 410 | 428,508 | 880,968 | (35,129) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 219,692 | ||||
Foreign currency translation adjustments | 4,638 | ||||
Other comprehensive income (loss), net of tax | $ 2,559 | ||||
Repurchase and retirement of common stock (in shares) | (1,528) | ||||
Repurchase and retirement of common stock | $ (100,292) | ||||
Ending balance (in shares) at Jan. 31, 2024 | 39,881 | 39,881 | |||
Ending balance at Jan. 31, 2024 | $ 1,418,944 | $ 398 | 345,818 | 1,100,660 | (27,932) |
Beginning balance (in shares) at Jul. 31, 2023 | 40,606 | ||||
Beginning balance at Jul. 31, 2023 | 1,354,806 | $ 406 | 404,944 | 967,798 | (18,342) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 80,957 | 80,957 | |||
Foreign currency translation adjustments | (21,164) | (21,164) | |||
Other comprehensive income (loss), net of tax | 4,214 | 4,214 | |||
Repurchase and retirement of common stock (in shares) | (689) | ||||
Repurchase and retirement of common stock | (44,572) | $ (6) | (44,566) | ||
Equity-based compensation | 5,111 | 5,111 | |||
Exercise of stock options (in shares) | 19 | ||||
Exercise of stock options | 508 | 508 | |||
Vesting of restricted stock units (in shares) | 119 | ||||
Vesting of restricted stock units | 0 | $ 1 | (1) | ||
Tax withholding related to net share settlements of equity awards | (3,975) | (3,975) | |||
Ending balance (in shares) at Oct. 31, 2023 | 40,055 | ||||
Ending balance at Oct. 31, 2023 | 1,375,885 | $ 401 | 362,021 | 1,048,755 | (35,292) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 51,905 | 51,905 | |||
Foreign currency translation adjustments | 14,404 | 14,404 | |||
Other comprehensive income (loss), net of tax | (7,044) | (7,044) | |||
Repurchase and retirement of common stock (in shares) | (370) | ||||
Repurchase and retirement of common stock | (24,936) | $ (4) | (24,932) | ||
Equity-based compensation | 3,559 | 3,559 | |||
Exercise of stock options (in shares) | 163 | ||||
Exercise of stock options | 3,297 | $ 1 | 3,296 | ||
Vesting of restricted stock units (in shares) | 2 | ||||
Tax withholding related to net share settlements of equity awards | (48) | (48) | |||
Issuance of common stock pursuant to employee stock purchase plan (in shares) | 31 | ||||
Issuance of common stock pursuant to employee stock purchase plan | $ 1,922 | 1,922 | |||
Ending balance (in shares) at Jan. 31, 2024 | 39,881 | 39,881 | |||
Ending balance at Jan. 31, 2024 | $ 1,418,944 | $ 398 | $ 345,818 | $ 1,100,660 | $ (27,932) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 9 Months Ended | |
Jan. 31, 2024 | Jan. 31, 2023 | |
Cash flows from operating activities: | ||
Net income | $ 219,692 | $ 257,398 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 97,759 | 96,085 |
Write-off and amortization of debt discount and debt issuance costs | 3,374 | 1,176 |
Equity-based compensation | 16,507 | 17,289 |
Gain on disposal of assets | (663) | (614) |
Deferred income taxes | (6,410) | (1,951) |
Other items, net | 3,876 | 5,891 |
Changes in assets and liabilities net of effects of acquisitions: | ||
Trade accounts and notes receivable | 2,691 | (28,148) |
Inventories | 7 | (34,717) |
Prepaid expenses and other assets | (19,184) | (907) |
Accounts payable | (56,803) | (51,491) |
Accrued compensation and employee benefits | (21,505) | (16,469) |
Other accrued expenses and liabilities | (10,315) | (6,615) |
Cash provided by operating activities | 229,026 | 236,927 |
Cash flows from investing activities: | ||
Purchases of property and equipment | (39,728) | (33,250) |
Proceeds from sale of assets | 1,948 | 1,661 |
Acquisition of businesses, net of cash acquired | (55,402) | (20,415) |
Cash used in investing activities | (93,182) | (52,004) |
Cash flows from financing activities: | ||
Repayments on revolving credit facilities | (525,009) | (361,247) |
Borrowings from revolving credit facilities | 443,973 | 390,113 |
Payments of principal on long-term debt | (1,250) | (3,832) |
Borrowings from term loan amendment | 288,266 | 0 |
Repayments from term loan amendment | (287,769) | 0 |
Payments of principal on finance lease obligations | (30,381) | (26,167) |
Repurchases of common stock | (100,292) | (82,767) |
Payment of acquisition holdback liability | 0 | (13,500) |
Payment for debt issuance costs | (5,825) | (3,157) |
Proceeds from exercises of stock options | 5,053 | 2,430 |
Payments for taxes related to net share settlement of equity awards | (4,023) | (4,005) |
Proceeds from issuance of stock pursuant to employee stock purchase plan | 4,586 | 3,203 |
Cash used in financing activities | (212,671) | (98,929) |
Effect of exchange rates on cash and cash equivalents | 423 | (1,247) |
(Decrease) increase in cash and cash equivalents | (76,404) | 84,747 |
Cash and cash equivalents, beginning of period | 164,745 | 101,916 |
Cash and cash equivalents, end of period | 88,341 | 186,663 |
Supplemental cash flow disclosures: | ||
Cash paid for income taxes | 93,661 | 85,642 |
Cash paid for interest | $ 57,300 | $ 49,193 |
Business, Basis of Presentation
Business, Basis of Presentation and Summary of Significant Accounting Policies | 9 Months Ended |
Jan. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Business, Basis of Presentation and Summary of Significant Accounting Policies | Business, Basis of Presentation and Summary of Significant Accounting Policies Business Founded in 1971, GMS Inc. (together with its consolidated subsidiaries, “we,” “our,” “us,” or the “Company”), through its operating subsidiaries, operates a network of more than 300 distribution centers with extensive product offerings of wallboard, ceilings, steel framing and complementary construction products. The Company also operates more than 100 tool sales, rental and service centers. Through these operations, the Company provides a comprehensive selection of building products and solutions for its residential and commercial contractor customer base across the United States and Canada. The Company’s unique operating model combines the benefits of a national platform and strategy with a local go-to-market focus, enabling the Company to generate significant economies of scale while maintaining high levels of customer service. Basis of Presentation The condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair presentation of the results of operations, financial position and cash flows. All adjustments are of a normal recurring nature unless otherwise disclosed. The results of operations for interim periods are not necessarily indicative of results for any other interim period or the entire fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 30, 2023. Principles of Consolidation The condensed consolidated financial statements present the results of operations, financial position, stockholders’ equity and cash flows of the Company and its subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. The results of operations of businesses acquired are included from their respective dates of acquisition. Use of Estimates The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Foreign Currency Translation Assets and liabilities of the Company’s Canadian subsidiaries are translated at the exchange rate prevailing at the balance sheet date, while income and expenses are translated at average rates for the period. Translation gains and losses are reported as a separate component of stockholders’ equity and other comprehensive income. Gains and losses on foreign currency transactions are recognized in the Condensed Consolidated Statements of Operations and Comprehensive Income within other income, net. Insurance Liabilities The Company is self-insured for certain losses related to medical claims. The Company has stop-loss coverage to limit the exposure arising from medical claims. In addition, the Company has deductible-based insurance policies for certain losses related to general liability, automobile and workers’ compensation. The expected ultimate cost for claims incurred as of the balance sheet date is not discounted and is recognized as a liability if probable and estimable. Insurance losses for claims filed and claims incurred but not reported are accrued based upon estimates of the aggregate liability for uninsured claims using historical loss development factors and actuarial assumptions followed in the insurance industry. The following table presents the Company’s aggregate liabilities for medical self-insurance, general liability, automobile and workers’ compensation and the expected recoveries for medical self-insurance, general liability, automobile and workers’ compensation. Liabilities for medical self-insurance are included in other accrued expenses and current liabilities. Reserves for general liability, automobile and workers’ compensation are included in other accrued expenses and current liabilities and other liabilities in the Condensed Consolidated Balance Sheets. Expected recoveries for insurance liabilities are included in prepaid expenses and other current assets and other assets in the Condensed Consolidated Balance Sheets. January 31, April 30, (in thousands) Medical self‑insurance $ 3,725 $ 4,275 General liability, automobile and workers’ compensation 23,745 20,502 Expected recoveries for insurance liabilities (5,477) (3,531) Revenue Recognition Revenue is recognized upon transfer of control of contracted goods to customers at an amount that reflects the consideration the Company expects to receive in exchange for those goods. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. The Company includes shipping and handling costs billed to customers in net sales. These costs are recognized as a component of selling, general and administrative expenses. See Note 13, “Segments,” for information regarding disaggregation of revenue, including revenue by product and by geographic area. Income Taxes The Company considers each interim period an integral part of the annual period and measures tax expense (benefit) using an estimated annual effective income tax rate. Estimates of the annual effective income tax rate at the end of interim periods are, out of necessity, based on evaluation of possible future events and transactions and may be subject to subsequent refinement or revision. The Company forecasts its estimated annual effective income tax rate and then applies that rate to its year-to-date pre-tax ordinary income (loss), subject to certain loss limitation provisions. In addition, certain specific transactions are excluded from the Company’s estimated annual effective tax rate computation but are discretely recognized within income tax expense (benefit) in their respective interim period. Future changes in annual income (loss) projections, tax rate changes, or discrete tax items could result in significant adjustments to quarterly income tax expense (benefit) in future periods. The Company evaluates its deferred tax assets quarterly to determine if valuation allowances are required. In this evaluation, the Company considers both positive and negative evidence in determining whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The primary negative evidence considered includes the cumulative operating losses generated in prior periods. The primary positive evidence considered includes the reversal of deferred tax liabilities related to depreciation and amortization that would occur within the same jurisdiction and during the carryforward period necessary to absorb the federal and state net operating losses and other deferred tax assets. Deferred tax assets and liabilities are computed by applying the federal, provincial and state income tax rates in effect to the gross amounts of temporary differences and other tax attributes, such as net operating loss carry-forwards. In assessing if the deferred tax assets will be realized, the Company considers whether it is more likely than not that some or all of these deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which these deductible temporary differences reverse. Earnings Per Share Basic earnings per share is computed by dividing net income available to common stockholders by the weighted average number of outstanding shares of common stock for the period. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock, including stock options and restricted stock units (collectively “Common Stock Equivalents”), were exercised or converted into common stock. The dilutive effect of outstanding stock options and restricted stock units is reflected in diluted earnings per share by application of the treasury stock method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amount of compensation cost attributed to future services and not yet recognized. Diluted earnings per share is computed by increasing the weighted-average number of outstanding shares of common stock computed in basic earnings per share to include the dilutive effect of Common Stock Equivalents for the period. In periods of net loss, the number of shares used to calculate diluted loss per share is the same as basic net loss per share. Recently Issued Accounting Pronouncements Segment Reporting . In November 2023, the Financial Accounting Standards Board ("FASB") issued new guidance to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker ("CODM"). The new guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The new guidance will apply retrospectively to all periods presented. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements. Income Taxes. In December 2023, the FASB issued new guidance t o enhance income tax disclosures primarily through changes in the rate reconciliation and income taxes paid disclosures . The new guidance is effective for fiscal years beginning after December 15, 2024. The new guidance will apply on a prospective basis to annual financial statements for periods beginning after the effective date. However, retrospective application in all prior periods presented is permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements. |
Business Combinations
Business Combinations | 9 Months Ended |
Jan. 31, 2024 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combinations | Business Combinations The Company accounts for business combinations by recognizing the assets acquired and liabilities assumed at the acquisition date fair value. In valuing certain acquired assets and liabilities, fair value estimates use Level 3 inputs, including future expected cash flows and discount rates. Goodwill is measured as the excess of consideration transferred over the fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to value assets acquired and liabilities assumed at the acquisition date, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments arising from new facts and circumstances are recorded to the Consolidated Statements of Operations and Comprehensive Income. The results of operations of acquisitions are reflected in the Company’s Consolidated Financial Statements from the date of acquisition. Pending Acquisition On December 18, 2023, the Company entered into a definitive agreement to acquire Kamco Supply Corporation and affiliates ("Kamco") for a purchase price of $321.5 million, inclusive of additional consideration in connection with the exit of a legacy pension fund. The Company expects to fund this transaction with cash on hand and borrowings under the Company’s revolving credit facility. Kamco is a leading regional supplier of ceilings, wallboard, steel, lumber, and other related construction products. Kamco operates five distribution facilities in the greater New York City area and services the New York metro and tri-state area. The transaction is expected to close during the fourth quarter of fiscal 2024, subject to the satisfaction of customary closing conditions. Fiscal 2024 Acquisitions On May 1, 2023, the Company acquired Jawl Lumber Corporation ("Jawl"), which provides service to the Vancouver Island market in Canada under the Home Lumber and Building Supplies ("Home Lumber") brand name. Home Lumber is a leading supplier of lumber, engineered wood, doors, framing packages and siding as well as other key complementary building materials. Home Lumber operates from a single location in Victoria, Canada. The primary purpose of the transaction was to expand the geographical coverage of the Company and grow the business. The impact of this acquisition is not material to the Company’s Consolidated Financial Statements. On October 1, 2023, the Company acquired AMW Construction Supply, LLC ("AMW"), a tools and fasteners and other complementary products distributor servicing the Phoenix, Arizona metro area. AMW operates from a single location in Phoenix, Arizona. The primary purpose of the transaction was to expand the Company's complementary product offerings and grow the business. The impact of this acquisition is not material to the Company’s Consolidated Financial Statements. The assets acquired and liabilities assumed were recognized at their acquisition date fair values. The acquisition accounting is subject to change as the Company obtains additional information during the measurement period about the facts and circumstances that existed as of the acquisition date. The primary areas of the preliminary acquisition accounting that are not yet finalized relate to preliminary fair value estimates, working capital adjustments and residual goodwill. The following table summarizes the preliminary acquisition accounting for the Company's fiscal 2024 acquisitions of Jawl and AMW based on currently available information: Preliminary Adjustments Preliminary (in thousands) Cash $ 3,027 $ — $ 3,027 Trade accounts and notes receivable 4,602 (176) 4,426 Inventories 8,181 — 8,181 Other assets 2,945 — 2,945 Customer relationships 27,554 (4,353) 23,201 Tradenames 6,064 (664) 5,400 Goodwill 17,443 3,487 20,930 Accounts payable and other liabilities (3,622) 24 (3,598) Deferred income taxes (6,586) 1,181 (5,405) Fair value of consideration transferred $ 59,608 $ (501) $ 59,107 |
Accounts Receivable
Accounts Receivable | 9 Months Ended |
Jan. 31, 2024 | |
Receivables [Abstract] | |
Accounts Receivable | Accounts Receivable The Company’s trade accounts and notes receivable consisted of the following: January 31, April 30, (in thousands) Trade receivables $ 671,201 $ 713,372 Other receivables 139,068 92,496 Allowance for expected credit losses (9,132) (8,606) Other allowances (6,416) (5,030) Trade accounts and notes receivable $ 794,721 $ 792,232 The following table presents the change in the allowance for expected credit losses during the nine months ended January 31, 2024: (in thousands) Balance as of April 30, 2023 $ 8,606 Provision 783 Other, net (257) Balance as of January 31, 2024 $ 9,132 Receivables from contracts with customers, net of allowances, were $655.7 million and $699.7 million as of January 31, 2024 and April 30, 2023, respectively. The Company did not have material amounts of contract assets or liabilities as of January 31, 2024 or April 30, 2023. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 9 Months Ended |
Jan. 31, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill The following table presents changes in the carrying amount of goodwill: Gross Accumulated Net Carrying Amount Impairment Loss Carrying Amount (in thousands) Balance as of April 30, 2023 $ 765,314 $ (64,501) $ 700,813 Goodwill recognized from acquisitions 20,930 — 20,930 Acquisition accounting adjustments from prior period (132) — (132) Translation adjustment 1,907 (493) 1,414 Balance as of January 31, 2024 $ 788,019 $ (64,994) $ 723,025 As of January 31, 2024, $615.2 million of goodwill was assigned to the Company's geographic divisions reportable segment and $107.8 million was assigned to the Company's other segment. During the nine months ended January 31, 2024, the Company recorded measurement period adjustments related to its Engler, Meier and Justus, Inc. and Blair Building Materials, Inc. acquisitions. Intangible Assets The following tables present the components of the Company’s intangible assets: Estimated Weighted January 31, 2024 Gross Accumulated Net (dollars in thousands) Customer relationships 5-16 12.4 $ 686,471 $ (466,614) $ 219,857 Definite-lived tradenames 5-20 15.5 106,118 (30,735) 75,383 Vendor agreements 10 10.0 1,000 (650) 350 Developed technology 5-10 6.9 8,313 (5,882) 2,431 Other 3-5 3.2 1,551 (1,325) 226 Definite-lived intangible assets 12.7 $ 803,453 $ (505,206) $ 298,247 Indefinite-lived intangible assets 84,367 Total intangible assets, net $ 382,614 Estimated Weighted April 30, 2023 Gross Accumulated Net (dollars in thousands) Customer relationships 5-16 12.4 $ 669,142 $ (432,220) $ 236,922 Definite-lived tradenames 5-20 15.6 100,326 (25,407) 74,919 Vendor agreements 8-10 10.0 1,000 (575) 425 Developed technology 5-10 6.9 8,261 (5,596) 2,665 Other 3-5 3.2 1,551 (1,189) 362 Definite-lived intangible assets 12.8 $ 780,280 $ (464,987) $ 315,293 Indefinite-lived intangible assets 84,367 Total intangible assets, net $ 399,660 Amortization expense related to definite-lived intangible assets was $15.5 million and $16.3 million for the three months ended January 31, 2024 and 2023, respectively, and $47.2 million and $50.9 million for the nine months ended January 31, 2024 and 2023, respectively. The following table summarizes the estimated future amortization expense for definite-lived intangible assets. Actual amortization expense to be reported in future periods could differ materially from these estimates as a result of acquisitions, changes in useful lives, foreign currency exchange rate fluctuations and other relevant factors. Year Ending April 30, (in thousands) 2024 (remaining three months) $ 14,236 2025 53,109 2026 44,908 2027 38,761 2028 32,141 Thereafter 115,092 Total $ 298,247 The Company’s indefinite-lived intangible assets as of January 31, 2024 and April 30, 2023 consisted of indefinite-lived tradenames. |
Long-Term Debt
Long-Term Debt | 9 Months Ended |
Jan. 31, 2024 | |
Debt Disclosure [Abstract] | |
Long-Term Debt | Long-Term Debt The Company’s long-term debt consisted of the following: January 31, April 30, (in thousands) Term Loan Facility $ 498,750 $ 499,503 Unamortized discount and deferred financing costs on Term Loan Facility (6,106) (2,442) Senior Notes 350,000 350,000 Unamortized discount and deferred financing costs on Senior Notes (3,596) (4,113) ABL Facility 29,000 110,000 Finance lease obligations 158,437 137,303 Installment notes at fixed rates up to 5.0%, due in monthly and annual installments through 2028 4,293 8,529 Unamortized discount on installment notes (17) (103) Carrying value of debt 1,030,761 1,098,677 Less current portion 48,094 54,035 Long-term debt $ 982,667 $ 1,044,642 Term Loan Facility The Company has a senior secured first lien term loan facility (the “Term Loan Facility”) with $498.8 million outstanding as of January 31, 2024. The Company is required to make scheduled quarterly payments of $1.3 million, or 0.25% of the aggregate principal amount of the Term Loan Facility, beginning January 1, 2024 with the remaining balance due May 12, 2030. As of January 31, 2024, the applicable rate of interest under the Term Loan Facility was 8.33%. As discussed in Note 15, “Subsequent Event”, the Term Loan Facility was amended on February 2, 2024, to reduce the interest rate applicable to the outstanding borrowings under the Term Loan Facility. Following such amendment, borrowings under the Term Loan Facility bear interest at a floating rate per annum based on the Secured Overnight Financing Rate ("SOFR") plus 2.25%. The Company has interest rate swap and collar agreements to convert the variable interest rate on a portion of its Term Loan Facility to a fixed rate. For more information, see Note 11, "Fair Value Measurements." On May 12, 2023, the Company amended the Term Loan Facility to provide refinancing term loans in the aggregate principal amount of $500.0 million, the net proceeds of which were used, together with cash on hand, to refinance the then outstanding borrowings under the Term Loan Facility in the principal amount of $499.5 million and pay related fees. The net $0.5 million increase in aggregate principal amount consisted of a $211.7 million cashless roll by existing lenders, $288.3 million of proceeds received from new lenders and $287.8 million of payments to lenders who did not participate in the refinancing. During the six months ended October 31, 2023, the Company corrected the presentation of the cash flows associated with the refinancing from a net presentation as shown in the cash flow statement for the three-month period ended July 31, 2023 to a presentation reporting the gross cash inflows and outflows within financing activities in the Condensed Consolidated Statement of Cash Flows. There was no impact to any of the cash flow subtotals (operating, investing, or financing) as a result of this correction of an immaterial cash flow misstatement. The amendment also amended the Term Loan Facility to, among other things, (i) replace the administrative and collateral agent, (ii) extend the maturity date by seven years from the date of the amendment to May 12, 2030 and (iii) modify certain thresholds, baskets and amounts referenced therein. The Company recorded a write-off of debt discount and deferred financing fees of $1.4 million, which is included in write-off of debt discount and deferred financing fees in the Consolidated Statement of Operations and Comprehensive Income for the nine months ended January 31, 2024. Senior Notes The Company has senior unsecured notes due May 2029 (the "Senior Notes") in the aggregate principal amount of $350.0 million. The Senior Notes bear interest at 4.625% per annum and mature on May 1, 2029. Interest is payable semi-annually in arrears on May 1 and November 1. Asset Based Lending Facility The Company has an asset based revolving credit facility (the “ABL Facility”) that provides for aggregate revolving commitments of $950.0 million as of January 31, 2024. Extensions of credit under the ABL Facility are limited by a borrowing base calculated periodically based on specified percentages of the value of eligible inventory and accounts receivable, subject to certain reserves and other adjustments. As of January 31, 2024, at the Company’s option, the interest rates applicable to the loans under the ABL Facility were based on SOFR or base rate plus, in each case, an applicable margin. The margins applicable for each elected interest rate are subject to a pricing grid, as defined in the ABL Facility agreement, based on average daily availability for the most recent fiscal quarter. The ABL Facility also contains an unused commitment fee. As of January 31, 2024, the weighted average interest rate on borrowings was 8.75%. As of January 31, 2024, the Company had available borrowing capacity of approximately $813.4 million under the ABL Facility. The ABL Facility matures on December 22, 2027. The ABL Facility contains a cross default provision with the Term Loan Facility. Debt Covenants The Term Loan Facility and the indenture governing the Senior Notes contain a number of covenants that limit our ability and the ability of our restricted subsidiaries, as described in the respective credit agreement and the indenture, to incur more indebtedness; pay dividends, redeem or repurchase stock or make other distributions; make investments; create restrictions on the ability of our restricted subsidiaries to pay dividends to us or make other intercompany transfers; create liens securing indebtedness; transfer or sell assets; merge or consolidate; enter into certain transactions with our affiliates; and prepay or amend the terms of certain indebtedness. Such covenants are subject to several important exceptions and qualifications set forth in the Term Loan Facility and the indenture governing the Senior Notes. As of January 31, 2024, the Company was in compliance with all covenants contained in the Term Loan Facility and the indenture governing the Senior Notes. The ABL Facility contains certain covenants, including financial and other reporting requirements. The Company was in compliance with all such covenants as of January 31, 2024. Debt Maturities As of January 31, 2024, the maturities of long-term debt were as follows: Term Loan Senior Notes ABL Facility Finance Installment Total Year Ending April 30, (in thousands) 2024 (remaining three months) $ 1,250 $ — $ — $ 11,103 $ 74 $ 12,427 2025 5,000 — — 41,549 1,615 48,164 2026 5,000 — — 35,742 714 41,456 2027 5,000 — — 30,220 694 35,914 2028 5,000 — 29,000 23,409 620 58,029 Thereafter 477,500 350,000 — 16,414 576 844,490 $ 498,750 $ 350,000 $ 29,000 $ 158,437 $ 4,293 $ 1,040,480 |
Leases
Leases | 9 Months Ended |
Jan. 31, 2024 | |
Lessee Disclosure [Abstract] | |
Leases | Leases The components of lease expense were as follows: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) Finance lease cost: Amortization of right-of-use assets $ 7,419 $ 6,121 $ 21,297 $ 17,918 Interest on lease liabilities 2,072 1,800 5,826 5,361 Operating lease cost 16,231 13,293 47,980 39,272 Variable lease cost 4,155 4,919 12,594 16,499 Total lease cost $ 29,877 $ 26,133 $ 87,697 $ 79,050 Supplemental cash flow information related to leases was as follows: Nine Months Ended 2024 2023 (in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 46,835 $ 39,675 Operating cash flows from finance leases 5,826 5,361 Financing cash flows from finance leases 30,381 26,167 Right-of-use assets obtained in exchange for lease obligations Operating leases 39,865 34,607 Finance leases 55,662 42,421 Other information related to leases was as follows: January 31, April 30, (in thousands) Finance leases included in property and equipment Property and equipment $ 269,168 $ 231,488 Accumulated depreciation (71,529) (65,274) Property and equipment, net $ 197,639 $ 166,214 Weighted-average remaining lease term (years) Operating leases 5.3 5.2 Finance leases 4.0 3.9 Weighted-average discount rate Operating leases 5.6 % 5.0 % Finance leases 5.5 % 4.9 % Future minimum lease payments under non-cancellable leases as of January 31, 2024 were as follows: Finance Operating Year Ending April 30, (in thousands) 2024 (remaining three months) $ 13,149 $ 12,390 2025 48,416 57,863 2026 40,708 45,063 2027 33,504 33,420 2028 25,196 23,704 Thereafter 17,140 54,334 Total lease payments 178,113 226,774 Less imputed interest 19,676 32,731 Total $ 158,437 $ 194,043 |
Leases | Leases The components of lease expense were as follows: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) Finance lease cost: Amortization of right-of-use assets $ 7,419 $ 6,121 $ 21,297 $ 17,918 Interest on lease liabilities 2,072 1,800 5,826 5,361 Operating lease cost 16,231 13,293 47,980 39,272 Variable lease cost 4,155 4,919 12,594 16,499 Total lease cost $ 29,877 $ 26,133 $ 87,697 $ 79,050 Supplemental cash flow information related to leases was as follows: Nine Months Ended 2024 2023 (in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 46,835 $ 39,675 Operating cash flows from finance leases 5,826 5,361 Financing cash flows from finance leases 30,381 26,167 Right-of-use assets obtained in exchange for lease obligations Operating leases 39,865 34,607 Finance leases 55,662 42,421 Other information related to leases was as follows: January 31, April 30, (in thousands) Finance leases included in property and equipment Property and equipment $ 269,168 $ 231,488 Accumulated depreciation (71,529) (65,274) Property and equipment, net $ 197,639 $ 166,214 Weighted-average remaining lease term (years) Operating leases 5.3 5.2 Finance leases 4.0 3.9 Weighted-average discount rate Operating leases 5.6 % 5.0 % Finance leases 5.5 % 4.9 % Future minimum lease payments under non-cancellable leases as of January 31, 2024 were as follows: Finance Operating Year Ending April 30, (in thousands) 2024 (remaining three months) $ 13,149 $ 12,390 2025 48,416 57,863 2026 40,708 45,063 2027 33,504 33,420 2028 25,196 23,704 Thereafter 17,140 54,334 Total lease payments 178,113 226,774 Less imputed interest 19,676 32,731 Total $ 158,437 $ 194,043 |
Income Taxes
Income Taxes | 9 Months Ended |
Jan. 31, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes General. The Company’s effective income tax rate on continuing operations was 24.5% and 26.3% for the nine months ended January 31, 2024 and 2023, respectively. The difference in the effective income tax rate over the U.S. federal statutory rate of 21.0% for the nine months ended January 31, 2024 and 2023 was primarily due to the impact of foreign taxes, state taxes and equity compensation. Valuation allowance . The Company had a valuation allowance of $11.8 million and $11.7 million against its deferred tax assets as of January 31, 2024 and April 30, 2023, respectively. To the extent the Company generates sufficient taxable income in the future to utilize the tax benefits of the net deferred tax assets on which a valuation allowance is recorded, the effective tax rate may decrease as the valuation allowance is reversed. Uncertain tax positions . The Company had no uncertain tax positions as of January 31, 2024 or April 30, 2023. |
Stockholders' Equity
Stockholders' Equity | 9 Months Ended |
Jan. 31, 2024 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders’ Equity Share Repurchases On October 18, 2023, the Company's Board of Directors approved an expanded share repurchase program under which the Company is authorized to repurchase up to $250.0 million of its outstanding common stock. This expanded program replaced the Company’s previous share repurchase authorization of $200.0 million. The Company may conduct repurchases under the share repurchase program through open market transactions, under trading plans in accordance with SEC Rule 10b5-1 and/or in privately negotiated transactions, in each case in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The timing and amount of any purchases of the Company's common stock are subject to a variety of factors, including, but not limited to, the Company’s liquidity, credit availability, general business and market conditions, debt covenants and the availability of alternative investment opportunities. The share repurchase program does not obligate the Company to acquire any amount of common stock, and it may be suspended or terminated at any time at the Company’s discretion. As of January 31, 2024, the Company had $216.5 million of remaining repurchase authorization under its stock repurchase program. Beginning January 1, 2023, share repurchases in excess of issuances are subject to a 1% excise tax. The Company includes the applicable excise tax as part of the cost basis of the shares acquired and records the taxes as a corresponding liability in accrued expenses and other liabilities in the Consolidated Balance Sheet. The following table presents share repurchase activity for the nine months ended January 31, 2024: Nine Months Ended 2024 2023 (in thousands) Amount repurchased pursuant to repurchase program $ 99,609 $ 82,767 Excise taxes on repurchases 683 — Repurchases of common stock $ 100,292 $ 82,767 Number of shares repurchased 1,528 1,773 Accumulated Other Comprehensive Loss The following table sets forth the changes to accumulated other comprehensive loss, net of tax, by component for the nine months ended January 31, 2024: Foreign Derivative Accumulated (in thousands) Balance as of April 30, 2023 $ (35,129) $ — $ (35,129) Other comprehensive income (loss) before reclassification (2,725) 4,643 1,918 Gains on intra-entity transactions that are of a long-term investment nature 7,363 — 7,363 Reclassification to earnings from accumulated other comprehensive loss — (2,084) (2,084) Balance as of January 31, 2024 $ (30,491) $ 2,559 $ (27,932) Other comprehensive income before reclassification on derivative instruments for the nine months ended January 31, 2024 is net of $1.5 million of tax. Reclassification to earnings from accumulated other comprehensive loss for the nine months ended January 31, 2024 is net of tax of $0.7 million. Gains on intra-entity transactions that are of a long-term investment nature for the nine months ended January 31, 2024 are net of tax of $1.2 million. |
Equity-Based Compensation
Equity-Based Compensation | 9 Months Ended |
Jan. 31, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Equity-Based Compensation | Equity-Based Compensation General Equity-based compensation expense related to stock options and restricted stock units was $11.0 million and $9.4 million during the nine months ended January 31, 2024 and 2023, respectively, and is included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income. Stock Option Awards The following table presents stock option activity for the nine months ended January 31, 2024: Number of Weighted Weighted Aggregate (shares and dollars in thousands) Outstanding as of April 30, 2023 1,106 $ 32.60 6.5 $ 28,155 Options granted 151 74.75 Options exercised (228) 22.12 Options forfeited (13) 42.11 Outstanding as of January 31, 2024 1,016 $ 41.11 6.8 $ 43,710 Exercisable as of January 31, 2024 680 $ 30.63 5.8 $ 36,409 Vested and Expected to vest as of January 31, 2024 1,015 $ 41.11 6.8 $ 43,701 The aggregate intrinsic value represents the excess of the Company’s closing stock price on the last trading day of the period over the weighted average exercise price, multiplied by the number of options outstanding, exercisable or expected to vest. Options expected to vest are unvested shares, net of expected forfeitures. The total intrinsic value of options exercised during the nine months ended January 31, 2024 and 2023 was $12.4 million and $6.5 million, respectively. As of January 31, 2024, there was $6.7 million of total unrecognized compensation cost related to stock options. That cost is expected to be recognized over a weighted-average period of 1.8 years. The fair value of stock options granted during the nine months ended January 31, 2024 and 2023 was estimated using the Black-Scholes option-pricing model with the following assumptions and resulting weighted average grant date fair value: Nine Months Ended 2024 2023 Volatility 38.70 % 45.80 % Expected life (years) 6.0 6.0 Risk-free interest rate 4.29 % 2.67 % Dividend yield — % — % Grant date fair value $ 33.33 $ 25.26 Restricted Stock Units The following table presents restricted stock unit activity for the nine months ended January 31, 2024: Number of Weighted (shares in thousands) Outstanding as of April 30, 2023 353 $ 46.97 Granted 141 74.80 Vested (175) 44.52 Forfeited (5) 52.39 Outstanding as of January 31, 2024 314 $ 60.74 The total fair value of awards vested during the nine months ended January 31, 2024 and 2023 was $13.0 million and $8.8 million, respectively. As of January 31, 2024, there was $9.5 million of total unrecognized compensation cost related to nonvested restricted stock units. That cost is expected to be recognized over a weighted-average period of 1.5 years. Employee Stock Purchase Plan The Company has an employee stock purchase plan (“ESPP”), the terms of which allow for qualified employees to participate in the purchase of shares of the Company’s common stock at a price equal to 90% of the lower of the closing price at the beginning or end of the purchase period, which is a six-month period ending on December 31 and June 30 of each year. The Company recognized $1.0 million and $0.8 million of stock-based compensation expense related to the ESPP during the nine months ended January 31, 2024 and 2023, respectively. The following table presents the number of shares of the Company’s common stock purchased under the ESPP and average price per share: Nine Months Ended 2024 2023 (shares in thousands) Number of shares purchased under the ESPP 89 79 Average purchase price $ 51.74 $ 40.47 |
Stock Appreciation Rights, Defe
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests | 9 Months Ended |
Jan. 31, 2024 | |
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests | |
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests | Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests The following table presents a summary of changes to the liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests: Stock Deferred Redeemable (in thousands) Balance as of April 30, 2023 $ 32,432 $ 2,407 $ 12,002 Amounts redeemed (1,810) (586) (2,931) Change in fair value 3,408 160 965 Balance as of January 31, 2024 $ 34,030 $ 1,981 $ 10,036 Classified as current as of April 30, 2023 $ 7,446 $ 545 $ 2,726 Classified as long-term as of April 30, 2023 24,986 1,862 9,276 Classified as current as of January 31, 2024 $ 8,123 $ 684 $ 3,423 Classified as long-term as of January 31, 2024 25,907 1,297 6,613 Total expense related to these instruments was $4.5 million and $7.1 million during the nine months ended January 31, 2024 and 2023, respectively, and was included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income. Current and long-term liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests are included in other accrued expenses and current liabilities and other liabilities, respectively, in the Condensed Consolidated Balance Sheets. See Note 13, "Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests," in the Company's Annual Report on Form 10-K for the year ended April 30, 2023 for more information regarding stock appreciation rights, deferred compensation and redeemable noncontrolling interests. |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Jan. 31, 2024 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table presents the estimated carrying amount and fair value of the Company’s assets and liabilities measured at fair value on a recurring basis: January 31, April 30, (in thousands) Interest rate swaps and collars (Level 2) $ 3,390 $ — In connection with the amendment to the Term Loan Facility in May 2023, the Company entered into (a) interest rate swap agreements for two years with notional amounts totaling $300.0 million to convert the variable interest rate on a portion of the term loans outstanding to a fixed 1-month SOFR interest rate of 3.899% and (b) forward interest rate collars with notional amounts totaling $300.0 million for years 2025 through 2029. The objective of such hedging instruments is to reduce the variability of interest payment cash flows associated with the variable interest rates under the Term Loan Facility and otherwise hedge exposure to future interest rate fluctuations. The Company believes there have been no material changes in the creditworthiness of the counterparties to these interest rate swaps and believes the risk of nonperformance by each party is minimal. The Company designated the interest rate swaps and collars as cash flow hedges. As of January 31, 2024, $2.2 million of the interest rate swap assets were classified in prepaid expenses and other current assets in the Condensed Consolidated Balance Sheet and $1.2 million were classified in other assets. The Company recognized gains, net of tax, of $0.8 million and $2.1 million during the three and nine months ended January 31, 2024, respectively, related to its interest rate swaps. This amount is included in interest expense in the Condensed Consolidated Statements of Operations and Comprehensive Income and within cash flows from operating activities within the Condensed Consolidated Statements of Cash Flows. As of January 31, 2024, the Company expects that approximately $2.2 million of pre- tax earnings will be reclassified from accumulated other comprehensive income (loss) into earnings during the next twelve months. The fair value of interest rate swap and collar agreements is determined using Level 2 inputs. Generally, the Company obtains the Level 2 inputs from its counterparties. Substantially all the inputs throughout the full term of the instruments can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. The fair value of the Company’s interest rate swap and collar agreements was determined using widely accepted valuation techniques, including a discounted cash flow analysis on the expected cash flows of the derivative. This analysis reflected the contractual terms of the derivatives, including the period to maturity, and used observable market-based inputs, including interest rate curves and implied volatilities. Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis Disclosures are required for certain assets and liabilities that are measured at fair value on a nonrecurring basis in periods after initial recognition. Such measurements of fair value relate primarily to assets and liabilities measured at fair value in connection with business combinations and long-lived asset impairments. For more information on business combinations, see Note 2, “Business Combinations.” There were no material long-lived asset impairments during the nine months ended January 31, 2024 or 2023. Fair Value of Debt The estimated fair value of the Company’s Senior Notes was determined based on Level 2 input using observable market prices in less active markets. The carrying amounts of the Company’s Term Loan Facility and ABL Facility approximate their fair value as the interest rates are variable and reflective of market rates. The following table presents the carrying amount and fair value of the Company’s Senior Notes: January 31, 2024 April 30, 2023 Carrying Amount Fair Value Carrying Amount Fair Value (in thousands) Senior Notes $ 350,000 $ 324,188 $ 350,000 $ 308,000 |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Jan. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies The Company is a defendant in various lawsuits and administrative actions associated with personal injuries, property damage, environmental matters, product liability claims, claims of former employees and other events arising in the normal course of business. As discussed in Note 1 “—Insurance Liabilities”, the Company records liabilities for these claims, and assets for amounts recoverable from the insurer, for claims covered by insurance. |
Segments
Segments | 9 Months Ended |
Jan. 31, 2024 | |
Segment Reporting [Abstract] | |
Segments | Segments There have been no changes to the Company's reportable segments during the nine months ended January 31, 2024. For more information regarding the Company's reportable segments, see Note 16, "Segments," in the Company's Annual Report on Form 10-K for the year ended April 30, 2023. Segment Results The following tables present segment results: Three Months Ended January 31, 2024 Net Sales Gross Profit Depreciation and Adjusted (in thousands) Geographic divisions $ 1,224,907 $ 399,000 $ 29,179 $ 124,911 Other 33,441 15,720 3,544 3,109 Corporate — — 81 — $ 1,258,348 $ 414,720 $ 32,804 $ 128,020 Three Months Ended January 31, 2023 Net Sales Gross Profit Depreciation and Adjusted (in thousands) Geographic divisions $ 1,201,183 $ 384,093 $ 27,159 $ 133,792 Other 33,435 18,155 4,140 7,036 Corporate — — 120 — $ 1,234,618 $ 402,248 $ 31,419 $ 140,828 Nine Months Ended January 31, 2024 Net Sales Gross Profit Depreciation and Adjusted (in thousands) Geographic divisions $ 3,992,941 $ 1,272,880 $ 86,289 $ 454,503 Other 95,937 51,023 11,217 14,373 Corporate — — 253 — $ 4,088,878 $ 1,323,903 $ 97,759 $ 468,876 Nine Months Ended January 31, 2023 Net Sales Gross Profit Depreciation and Adjusted (in thousands) Geographic divisions $ 3,928,170 $ 1,244,099 $ 82,887 $ 486,968 Other 96,980 57,370 12,827 24,387 Corporate — — 371 — $ 4,025,150 $ 1,301,469 $ 96,085 $ 511,355 The following table presents a reconciliation of Adjusted EBITDA to net income: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) Net income $ 51,905 $ 64,775 $ 219,692 $ 257,398 Interest expense 18,784 16,943 56,440 47,659 Write-off of debt discount and deferred financing fees — — 1,401 — Interest income (378) (180) (1,144) (390) Provision for income taxes 17,468 23,697 71,407 91,722 Depreciation expense 17,276 15,162 50,566 45,213 Amortization expense 15,528 16,257 47,193 50,872 Stock appreciation rights(a) 1,789 314 3,408 5,888 Redeemable noncontrolling interests and deferred compensation(b) 461 368 1,125 1,203 Equity-based compensation(c) 3,559 3,285 11,974 10,198 Severance and other permitted costs(d) 1,033 (315) 2,321 416 Transaction costs (acquisitions and other)(e) 765 476 3,373 1,154 Gain on disposal of assets(f) (222) (411) (663) (614) Effects of fair value adjustments to inventory(g) 8 457 450 636 Debt transaction costs(h) 44 — 1,333 — Adjusted EBITDA $ 128,020 $ 140,828 $ 468,876 $ 511,355 __________________________________________ (a) Represents changes in the fair value of stock appreciation rights. (b) Represents changes in the fair values of noncontrolling interests and deferred compensation agreements. (c) Represents non-cash equity-based compensation expense related to the issuance of share-based awards. (d) Represents severance expenses and certain other cost adjustments as permitted under the ABL Facility and the Term Loan Facility. (e) Represents costs related to acquisitions paid to third parties. (f) Includes gains and losses from the sale and disposal of assets. (g) Represents the non-cash cost of sales impact of acquisition accounting adjustments to increase inventory to its estimated fair value. (h) Represents costs paid to third-party advisors related to debt refinancing activities. Revenues by Product The following table presents the Company’s net sales to external customers by main product lines: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) Wallboard $ 520,686 $ 500,710 $ 1,677,285 $ 1,606,821 Complementary products 378,555 352,647 1,233,084 1,157,144 Steel framing 203,363 234,451 672,231 787,499 Ceilings 155,744 146,810 506,278 473,686 Total net sales $ 1,258,348 $ 1,234,618 $ 4,088,878 $ 4,025,150 Geographic Information The following table presents the Company’s net sales by major geographic area: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) United States $ 1,107,244 $ 1,089,888 $ 3,564,530 $ 3,530,083 Canada 151,104 144,730 524,348 495,067 Total net sales $ 1,258,348 $ 1,234,618 $ 4,088,878 $ 4,025,150 The following table presents the Company’s property and equipment, net, by major geographic area: January 31, April 30, (in thousands) United States $ 390,788 $ 354,652 Canada 46,598 41,767 Total property and equipment, net $ 437,386 $ 396,419 |
Earnings Per Common Share
Earnings Per Common Share | 9 Months Ended |
Jan. 31, 2024 | |
Earnings Per Share [Abstract] | |
Earnings Per Common Share | Earnings Per Common Share The following table sets forth the computation of basic and diluted earnings per share of common stock: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands, except per share data) Net income $ 51,905 $ 64,775 $ 219,692 $ 257,398 Basic earnings per common share: Basic weighted average common shares outstanding 39,864 41,578 40,360 42,119 Basic earnings per common share $ 1.30 $ 1.56 $ 5.44 $ 6.11 Diluted earnings per common share: Basic weighted average common shares outstanding 39,864 41,578 40,360 42,119 Add: Common Stock Equivalents 648 654 666 693 Diluted weighted average common shares outstanding 40,512 42,232 41,026 42,812 Diluted earnings per common share $ 1.28 $ 1.53 $ 5.35 $ 6.01 During the three and nine months ended January 31, 2024 and 2023, the number of Common Stock Equivalents excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive was not material. Anti-dilutive securities could be dilutive in future periods. |
Subsequent Event
Subsequent Event | 9 Months Ended |
Jan. 31, 2024 | |
Subsequent Events [Abstract] | |
Subsequent Event | Subsequent Event On February 2, 2024, the Company amended its Term Loan Facility to reduce the interest rate applicable to the outstanding borrowings under the Term Loan Facility. The applicable rate for term SOFR loans under the Term Loan Facility was reduced from a floating rate per annum of Term SOFR (as defined in the Term Loan Facility) plus 3.00% to a floating rate per annum of Term SOFR plus 2.25% and the applicable rate for base rate loans under the Term Loan Facility was reduced from a floating rate per annum of the Base Rate (as defined in the Term Loan Facility) plus 2.00% to a floating rate per annum of the Base Rate plus 1.25%. The other material terms of the Term Loan Facility remain unchanged. |
Business, Basis of Presentati_2
Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Jan. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair presentation of the results of operations, financial position and cash flows. All adjustments are of a normal recurring nature unless otherwise disclosed. The results of operations for interim periods are not necessarily indicative of results for any other interim period or the entire fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 30, 2023. |
Principles of Consolidation | Principles of Consolidation The condensed consolidated financial statements present the results of operations, financial position, stockholders’ equity and cash flows of the Company and its subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. The results of operations of businesses acquired are included from their respective dates of acquisition. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Foreign Currency Translation | Foreign Currency Translation Assets and liabilities of the Company’s Canadian subsidiaries are translated at the exchange rate prevailing at the balance sheet date, while income and expenses are translated at average rates for the period. Translation gains and losses are reported as a separate component of stockholders’ equity and other comprehensive income. Gains and losses on foreign currency transactions are recognized in the Condensed Consolidated Statements of Operations and Comprehensive Income within other income, net. |
Insurance Liabilities | Insurance Liabilities The Company is self-insured for certain losses related to medical claims. The Company has stop-loss coverage to limit the exposure arising from medical claims. In addition, the Company has deductible-based insurance policies for certain losses related to general liability, automobile and workers’ compensation. The expected ultimate cost for claims incurred as of the balance sheet date is not discounted and is recognized as a liability if probable and estimable. Insurance losses for claims filed and claims incurred but not reported are accrued based upon estimates of the aggregate liability for uninsured claims using historical loss development factors and actuarial assumptions followed in the insurance industry. |
Revenue Recognition | Revenue Recognition Revenue is recognized upon transfer of control of contracted goods to customers at an amount that reflects the consideration the Company expects to receive in exchange for those goods. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. The Company includes shipping and handling costs billed to customers in net sales. These costs are recognized as a component of selling, general and administrative expenses. |
Income Taxes | Income Taxes The Company considers each interim period an integral part of the annual period and measures tax expense (benefit) using an estimated annual effective income tax rate. Estimates of the annual effective income tax rate at the end of interim periods are, out of necessity, based on evaluation of possible future events and transactions and may be subject to subsequent refinement or revision. The Company forecasts its estimated annual effective income tax rate and then applies that rate to its year-to-date pre-tax ordinary income (loss), subject to certain loss limitation provisions. In addition, certain specific transactions are excluded from the Company’s estimated annual effective tax rate computation but are discretely recognized within income tax expense (benefit) in their respective interim period. Future changes in annual income (loss) projections, tax rate changes, or discrete tax items could result in significant adjustments to quarterly income tax expense (benefit) in future periods. The Company evaluates its deferred tax assets quarterly to determine if valuation allowances are required. In this evaluation, the Company considers both positive and negative evidence in determining whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The primary negative evidence considered includes the cumulative operating losses generated in prior periods. The primary positive evidence considered includes the reversal of deferred tax liabilities related to depreciation and amortization that would occur within the same jurisdiction and during the carryforward period necessary to absorb the federal and state net operating losses and other deferred tax assets. Deferred tax assets and liabilities are computed by applying the federal, provincial and state income tax rates in effect to the gross amounts of temporary differences and other tax attributes, such as net operating loss carry-forwards. In assessing if the deferred tax assets will be realized, the Company considers whether it is more likely than not that some or all of these deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which these deductible temporary differences reverse. |
Earnings Per Share | Earnings Per Share Basic earnings per share is computed by dividing net income available to common stockholders by the weighted average number of outstanding shares of common stock for the period. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock, including stock options and restricted stock units (collectively “Common Stock Equivalents”), were exercised or converted into common stock. The dilutive effect of outstanding stock options and restricted stock units is reflected in diluted earnings per share by application of the treasury stock method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amount of compensation cost attributed to future services and not yet recognized. Diluted earnings per share is computed by increasing the weighted-average number of outstanding shares of common stock computed in basic earnings per share to include the dilutive effect of Common Stock Equivalents for the period. In periods of net loss, the number of shares used to calculate diluted loss per share is the same as basic net loss per share. |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements Segment Reporting . In November 2023, the Financial Accounting Standards Board ("FASB") issued new guidance to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker ("CODM"). The new guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The new guidance will apply retrospectively to all periods presented. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements. Income Taxes. In December 2023, the FASB issued new guidance t o enhance income tax disclosures primarily through changes in the rate reconciliation and income taxes paid disclosures . The new guidance is effective for fiscal years beginning after December 15, 2024. The new guidance will apply on a prospective basis to annual financial statements for periods beginning after the effective date. However, retrospective application in all prior periods presented is permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements. |
Business, Basis of Presentati_3
Business, Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of medical self-insurance liabilities and recoveries | The following table presents the Company’s aggregate liabilities for medical self-insurance, general liability, automobile and workers’ compensation and the expected recoveries for medical self-insurance, general liability, automobile and workers’ compensation. Liabilities for medical self-insurance are included in other accrued expenses and current liabilities. Reserves for general liability, automobile and workers’ compensation are included in other accrued expenses and current liabilities and other liabilities in the Condensed Consolidated Balance Sheets. Expected recoveries for insurance liabilities are included in prepaid expenses and other current assets and other assets in the Condensed Consolidated Balance Sheets. January 31, April 30, (in thousands) Medical self‑insurance $ 3,725 $ 4,275 General liability, automobile and workers’ compensation 23,745 20,502 Expected recoveries for insurance liabilities (5,477) (3,531) |
Business Combinations (Tables)
Business Combinations (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of preliminary allocation of the consideration transferred | The following table summarizes the preliminary acquisition accounting for the Company's fiscal 2024 acquisitions of Jawl and AMW based on currently available information: Preliminary Adjustments Preliminary (in thousands) Cash $ 3,027 $ — $ 3,027 Trade accounts and notes receivable 4,602 (176) 4,426 Inventories 8,181 — 8,181 Other assets 2,945 — 2,945 Customer relationships 27,554 (4,353) 23,201 Tradenames 6,064 (664) 5,400 Goodwill 17,443 3,487 20,930 Accounts payable and other liabilities (3,622) 24 (3,598) Deferred income taxes (6,586) 1,181 (5,405) Fair value of consideration transferred $ 59,608 $ (501) $ 59,107 |
Accounts Receivable (Tables)
Accounts Receivable (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Receivables [Abstract] | |
Schedule of trade accounts and notes receivable | The Company’s trade accounts and notes receivable consisted of the following: January 31, April 30, (in thousands) Trade receivables $ 671,201 $ 713,372 Other receivables 139,068 92,496 Allowance for expected credit losses (9,132) (8,606) Other allowances (6,416) (5,030) Trade accounts and notes receivable $ 794,721 $ 792,232 |
Schedule of change in allowance for expected credit losses | The following table presents the change in the allowance for expected credit losses during the nine months ended January 31, 2024: (in thousands) Balance as of April 30, 2023 $ 8,606 Provision 783 Other, net (257) Balance as of January 31, 2024 $ 9,132 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of changes in the carrying amount of goodwill | The following table presents changes in the carrying amount of goodwill: Gross Accumulated Net Carrying Amount Impairment Loss Carrying Amount (in thousands) Balance as of April 30, 2023 $ 765,314 $ (64,501) $ 700,813 Goodwill recognized from acquisitions 20,930 — 20,930 Acquisition accounting adjustments from prior period (132) — (132) Translation adjustment 1,907 (493) 1,414 Balance as of January 31, 2024 $ 788,019 $ (64,994) $ 723,025 |
Schedule of components of definite-lived intangible assets | The following tables present the components of the Company’s intangible assets: Estimated Weighted January 31, 2024 Gross Accumulated Net (dollars in thousands) Customer relationships 5-16 12.4 $ 686,471 $ (466,614) $ 219,857 Definite-lived tradenames 5-20 15.5 106,118 (30,735) 75,383 Vendor agreements 10 10.0 1,000 (650) 350 Developed technology 5-10 6.9 8,313 (5,882) 2,431 Other 3-5 3.2 1,551 (1,325) 226 Definite-lived intangible assets 12.7 $ 803,453 $ (505,206) $ 298,247 Indefinite-lived intangible assets 84,367 Total intangible assets, net $ 382,614 Estimated Weighted April 30, 2023 Gross Accumulated Net (dollars in thousands) Customer relationships 5-16 12.4 $ 669,142 $ (432,220) $ 236,922 Definite-lived tradenames 5-20 15.6 100,326 (25,407) 74,919 Vendor agreements 8-10 10.0 1,000 (575) 425 Developed technology 5-10 6.9 8,261 (5,596) 2,665 Other 3-5 3.2 1,551 (1,189) 362 Definite-lived intangible assets 12.8 $ 780,280 $ (464,987) $ 315,293 Indefinite-lived intangible assets 84,367 Total intangible assets, net $ 399,660 |
Schedule of components of indefinite-lived intangible assets | The following tables present the components of the Company’s intangible assets: Estimated Weighted January 31, 2024 Gross Accumulated Net (dollars in thousands) Customer relationships 5-16 12.4 $ 686,471 $ (466,614) $ 219,857 Definite-lived tradenames 5-20 15.5 106,118 (30,735) 75,383 Vendor agreements 10 10.0 1,000 (650) 350 Developed technology 5-10 6.9 8,313 (5,882) 2,431 Other 3-5 3.2 1,551 (1,325) 226 Definite-lived intangible assets 12.7 $ 803,453 $ (505,206) $ 298,247 Indefinite-lived intangible assets 84,367 Total intangible assets, net $ 382,614 Estimated Weighted April 30, 2023 Gross Accumulated Net (dollars in thousands) Customer relationships 5-16 12.4 $ 669,142 $ (432,220) $ 236,922 Definite-lived tradenames 5-20 15.6 100,326 (25,407) 74,919 Vendor agreements 8-10 10.0 1,000 (575) 425 Developed technology 5-10 6.9 8,261 (5,596) 2,665 Other 3-5 3.2 1,551 (1,189) 362 Definite-lived intangible assets 12.8 $ 780,280 $ (464,987) $ 315,293 Indefinite-lived intangible assets 84,367 Total intangible assets, net $ 399,660 |
Schedule of estimated future aggregate amortization expense | The following table summarizes the estimated future amortization expense for definite-lived intangible assets. Actual amortization expense to be reported in future periods could differ materially from these estimates as a result of acquisitions, changes in useful lives, foreign currency exchange rate fluctuations and other relevant factors. Year Ending April 30, (in thousands) 2024 (remaining three months) $ 14,236 2025 53,109 2026 44,908 2027 38,761 2028 32,141 Thereafter 115,092 Total $ 298,247 |
Long-Term Debt (Tables)
Long-Term Debt (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Debt Disclosure [Abstract] | |
Schedule of long-term debt | The Company’s long-term debt consisted of the following: January 31, April 30, (in thousands) Term Loan Facility $ 498,750 $ 499,503 Unamortized discount and deferred financing costs on Term Loan Facility (6,106) (2,442) Senior Notes 350,000 350,000 Unamortized discount and deferred financing costs on Senior Notes (3,596) (4,113) ABL Facility 29,000 110,000 Finance lease obligations 158,437 137,303 Installment notes at fixed rates up to 5.0%, due in monthly and annual installments through 2028 4,293 8,529 Unamortized discount on installment notes (17) (103) Carrying value of debt 1,030,761 1,098,677 Less current portion 48,094 54,035 Long-term debt $ 982,667 $ 1,044,642 |
Scheduled of maturities of long-term debt | As of January 31, 2024, the maturities of long-term debt were as follows: Term Loan Senior Notes ABL Facility Finance Installment Total Year Ending April 30, (in thousands) 2024 (remaining three months) $ 1,250 $ — $ — $ 11,103 $ 74 $ 12,427 2025 5,000 — — 41,549 1,615 48,164 2026 5,000 — — 35,742 714 41,456 2027 5,000 — — 30,220 694 35,914 2028 5,000 — 29,000 23,409 620 58,029 Thereafter 477,500 350,000 — 16,414 576 844,490 $ 498,750 $ 350,000 $ 29,000 $ 158,437 $ 4,293 $ 1,040,480 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Lessee Disclosure [Abstract] | |
Summary of components of lease expense | The components of lease expense were as follows: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) Finance lease cost: Amortization of right-of-use assets $ 7,419 $ 6,121 $ 21,297 $ 17,918 Interest on lease liabilities 2,072 1,800 5,826 5,361 Operating lease cost 16,231 13,293 47,980 39,272 Variable lease cost 4,155 4,919 12,594 16,499 Total lease cost $ 29,877 $ 26,133 $ 87,697 $ 79,050 |
Summary of components of supplemental cash flow information related to leases | Supplemental cash flow information related to leases was as follows: Nine Months Ended 2024 2023 (in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 46,835 $ 39,675 Operating cash flows from finance leases 5,826 5,361 Financing cash flows from finance leases 30,381 26,167 Right-of-use assets obtained in exchange for lease obligations Operating leases 39,865 34,607 Finance leases 55,662 42,421 |
Summary of other lease information | Other information related to leases was as follows: January 31, April 30, (in thousands) Finance leases included in property and equipment Property and equipment $ 269,168 $ 231,488 Accumulated depreciation (71,529) (65,274) Property and equipment, net $ 197,639 $ 166,214 Weighted-average remaining lease term (years) Operating leases 5.3 5.2 Finance leases 4.0 3.9 Weighted-average discount rate Operating leases 5.6 % 5.0 % Finance leases 5.5 % 4.9 % |
Schedule of maturities for finance leases | Future minimum lease payments under non-cancellable leases as of January 31, 2024 were as follows: Finance Operating Year Ending April 30, (in thousands) 2024 (remaining three months) $ 13,149 $ 12,390 2025 48,416 57,863 2026 40,708 45,063 2027 33,504 33,420 2028 25,196 23,704 Thereafter 17,140 54,334 Total lease payments 178,113 226,774 Less imputed interest 19,676 32,731 Total $ 158,437 $ 194,043 |
Schedule of maturities for operating leases | Future minimum lease payments under non-cancellable leases as of January 31, 2024 were as follows: Finance Operating Year Ending April 30, (in thousands) 2024 (remaining three months) $ 13,149 $ 12,390 2025 48,416 57,863 2026 40,708 45,063 2027 33,504 33,420 2028 25,196 23,704 Thereafter 17,140 54,334 Total lease payments 178,113 226,774 Less imputed interest 19,676 32,731 Total $ 158,437 $ 194,043 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Equity [Abstract] | |
Schedule of share repurchase activity | The following table presents share repurchase activity for the nine months ended January 31, 2024: Nine Months Ended 2024 2023 (in thousands) Amount repurchased pursuant to repurchase program $ 99,609 $ 82,767 Excise taxes on repurchases 683 — Repurchases of common stock $ 100,292 $ 82,767 Number of shares repurchased 1,528 1,773 |
Schedule of changes to accumulated other comprehensive loss, net of tax, by component | The following table sets forth the changes to accumulated other comprehensive loss, net of tax, by component for the nine months ended January 31, 2024: Foreign Derivative Accumulated (in thousands) Balance as of April 30, 2023 $ (35,129) $ — $ (35,129) Other comprehensive income (loss) before reclassification (2,725) 4,643 1,918 Gains on intra-entity transactions that are of a long-term investment nature 7,363 — 7,363 Reclassification to earnings from accumulated other comprehensive loss — (2,084) (2,084) Balance as of January 31, 2024 $ (30,491) $ 2,559 $ (27,932) |
Equity-Based Compensation - (Ta
Equity-Based Compensation - (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of stock option activity | The following table presents stock option activity for the nine months ended January 31, 2024: Number of Weighted Weighted Aggregate (shares and dollars in thousands) Outstanding as of April 30, 2023 1,106 $ 32.60 6.5 $ 28,155 Options granted 151 74.75 Options exercised (228) 22.12 Options forfeited (13) 42.11 Outstanding as of January 31, 2024 1,016 $ 41.11 6.8 $ 43,710 Exercisable as of January 31, 2024 680 $ 30.63 5.8 $ 36,409 Vested and Expected to vest as of January 31, 2024 1,015 $ 41.11 6.8 $ 43,701 |
Schedule of the fair value of stock options assumptions | The fair value of stock options granted during the nine months ended January 31, 2024 and 2023 was estimated using the Black-Scholes option-pricing model with the following assumptions and resulting weighted average grant date fair value: Nine Months Ended 2024 2023 Volatility 38.70 % 45.80 % Expected life (years) 6.0 6.0 Risk-free interest rate 4.29 % 2.67 % Dividend yield — % — % Grant date fair value $ 33.33 $ 25.26 |
Summary of restricted stock unit activity | The following table presents restricted stock unit activity for the nine months ended January 31, 2024: Number of Weighted (shares in thousands) Outstanding as of April 30, 2023 353 $ 46.97 Granted 141 74.80 Vested (175) 44.52 Forfeited (5) 52.39 Outstanding as of January 31, 2024 314 $ 60.74 |
Schedule of ESPP activity | The following table presents the number of shares of the Company’s common stock purchased under the ESPP and average price per share: Nine Months Ended 2024 2023 (shares in thousands) Number of shares purchased under the ESPP 89 79 Average purchase price $ 51.74 $ 40.47 |
Stock Appreciation Rights, De_2
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests | |
Summary of changes to the liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests | The following table presents a summary of changes to the liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests: Stock Deferred Redeemable (in thousands) Balance as of April 30, 2023 $ 32,432 $ 2,407 $ 12,002 Amounts redeemed (1,810) (586) (2,931) Change in fair value 3,408 160 965 Balance as of January 31, 2024 $ 34,030 $ 1,981 $ 10,036 Classified as current as of April 30, 2023 $ 7,446 $ 545 $ 2,726 Classified as long-term as of April 30, 2023 24,986 1,862 9,276 Classified as current as of January 31, 2024 $ 8,123 $ 684 $ 3,423 Classified as long-term as of January 31, 2024 25,907 1,297 6,613 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Fair Value Disclosures [Abstract] | |
Schedule of liabilities measured at fair value on a recurring basis | The following table presents the estimated carrying amount and fair value of the Company’s assets and liabilities measured at fair value on a recurring basis: January 31, April 30, (in thousands) Interest rate swaps and collars (Level 2) $ 3,390 $ — |
Schedule of carrying value and fair value of the Senior Notes | The following table presents the carrying amount and fair value of the Company’s Senior Notes: January 31, 2024 April 30, 2023 Carrying Amount Fair Value Carrying Amount Fair Value (in thousands) Senior Notes $ 350,000 $ 324,188 $ 350,000 $ 308,000 |
Segments (Tables)
Segments (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Segment Reporting [Abstract] | |
Schedule of segment results | The following tables present segment results: Three Months Ended January 31, 2024 Net Sales Gross Profit Depreciation and Adjusted (in thousands) Geographic divisions $ 1,224,907 $ 399,000 $ 29,179 $ 124,911 Other 33,441 15,720 3,544 3,109 Corporate — — 81 — $ 1,258,348 $ 414,720 $ 32,804 $ 128,020 Three Months Ended January 31, 2023 Net Sales Gross Profit Depreciation and Adjusted (in thousands) Geographic divisions $ 1,201,183 $ 384,093 $ 27,159 $ 133,792 Other 33,435 18,155 4,140 7,036 Corporate — — 120 — $ 1,234,618 $ 402,248 $ 31,419 $ 140,828 Nine Months Ended January 31, 2024 Net Sales Gross Profit Depreciation and Adjusted (in thousands) Geographic divisions $ 3,992,941 $ 1,272,880 $ 86,289 $ 454,503 Other 95,937 51,023 11,217 14,373 Corporate — — 253 — $ 4,088,878 $ 1,323,903 $ 97,759 $ 468,876 Nine Months Ended January 31, 2023 Net Sales Gross Profit Depreciation and Adjusted (in thousands) Geographic divisions $ 3,928,170 $ 1,244,099 $ 82,887 $ 486,968 Other 96,980 57,370 12,827 24,387 Corporate — — 371 — $ 4,025,150 $ 1,301,469 $ 96,085 $ 511,355 |
Reconciliation of Adjusted EBITDA to net income | The following table presents a reconciliation of Adjusted EBITDA to net income: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) Net income $ 51,905 $ 64,775 $ 219,692 $ 257,398 Interest expense 18,784 16,943 56,440 47,659 Write-off of debt discount and deferred financing fees — — 1,401 — Interest income (378) (180) (1,144) (390) Provision for income taxes 17,468 23,697 71,407 91,722 Depreciation expense 17,276 15,162 50,566 45,213 Amortization expense 15,528 16,257 47,193 50,872 Stock appreciation rights(a) 1,789 314 3,408 5,888 Redeemable noncontrolling interests and deferred compensation(b) 461 368 1,125 1,203 Equity-based compensation(c) 3,559 3,285 11,974 10,198 Severance and other permitted costs(d) 1,033 (315) 2,321 416 Transaction costs (acquisitions and other)(e) 765 476 3,373 1,154 Gain on disposal of assets(f) (222) (411) (663) (614) Effects of fair value adjustments to inventory(g) 8 457 450 636 Debt transaction costs(h) 44 — 1,333 — Adjusted EBITDA $ 128,020 $ 140,828 $ 468,876 $ 511,355 __________________________________________ (a) Represents changes in the fair value of stock appreciation rights. (b) Represents changes in the fair values of noncontrolling interests and deferred compensation agreements. (c) Represents non-cash equity-based compensation expense related to the issuance of share-based awards. (d) Represents severance expenses and certain other cost adjustments as permitted under the ABL Facility and the Term Loan Facility. (e) Represents costs related to acquisitions paid to third parties. (f) Includes gains and losses from the sale and disposal of assets. (g) Represents the non-cash cost of sales impact of acquisition accounting adjustments to increase inventory to its estimated fair value. (h) Represents costs paid to third-party advisors related to debt refinancing activities. |
Schedule of net sales to external customers by main product lines | The following table presents the Company’s net sales to external customers by main product lines: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) Wallboard $ 520,686 $ 500,710 $ 1,677,285 $ 1,606,821 Complementary products 378,555 352,647 1,233,084 1,157,144 Steel framing 203,363 234,451 672,231 787,499 Ceilings 155,744 146,810 506,278 473,686 Total net sales $ 1,258,348 $ 1,234,618 $ 4,088,878 $ 4,025,150 |
Schedule of net sales by major geographic area | The following table presents the Company’s net sales by major geographic area: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands) United States $ 1,107,244 $ 1,089,888 $ 3,564,530 $ 3,530,083 Canada 151,104 144,730 524,348 495,067 Total net sales $ 1,258,348 $ 1,234,618 $ 4,088,878 $ 4,025,150 |
Schedule of property and equipment by major geographic area | The following table presents the Company’s property and equipment, net, by major geographic area: January 31, April 30, (in thousands) United States $ 390,788 $ 354,652 Canada 46,598 41,767 Total property and equipment, net $ 437,386 $ 396,419 |
Earnings Per Common Share (Tabl
Earnings Per Common Share (Tables) | 9 Months Ended |
Jan. 31, 2024 | |
Earnings Per Share [Abstract] | |
Schedule of computation of basic and diluted earnings per share of common stock | The following table sets forth the computation of basic and diluted earnings per share of common stock: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (in thousands, except per share data) Net income $ 51,905 $ 64,775 $ 219,692 $ 257,398 Basic earnings per common share: Basic weighted average common shares outstanding 39,864 41,578 40,360 42,119 Basic earnings per common share $ 1.30 $ 1.56 $ 5.44 $ 6.11 Diluted earnings per common share: Basic weighted average common shares outstanding 39,864 41,578 40,360 42,119 Add: Common Stock Equivalents 648 654 666 693 Diluted weighted average common shares outstanding 40,512 42,232 41,026 42,812 Diluted earnings per common share $ 1.28 $ 1.53 $ 5.35 $ 6.01 |
Business, Basis of Presentati_4
Business, Basis of Presentation and Summary of Significant Accounting Policies - Business (Details) | 9 Months Ended |
Jan. 31, 2024 center | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of distribution centers (more than) | 300 |
Number of retail locations (more than) | 100 |
Business, Basis of Presentati_5
Business, Basis of Presentation and Summary of Significant Accounting Policies - Insurance Liabilities (Details) - General liability, workers' compensation and automobile - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Loss contingencies | ||
Medical self‑insurance | $ 3,725 | $ 4,275 |
General liability, automobile and workers’ compensation | 23,745 | 20,502 |
Expected recoveries for insurance liabilities | $ (5,477) | $ (3,531) |
Business Combinations - Narrati
Business Combinations - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended |
Apr. 30, 2024 | Jan. 31, 2024 | Apr. 30, 2023 | |
Business Acquisition [Line Items] | |||
Estimated useful life (in years) | 12 years 8 months 12 days | 12 years 9 months 18 days | |
Customer relationships | |||
Business Acquisition [Line Items] | |||
Estimated useful life (in years) | 12 years 4 months 24 days | 12 years 4 months 24 days | |
Tradenames | |||
Business Acquisition [Line Items] | |||
Estimated useful life (in years) | 15 years 6 months | 15 years 7 months 6 days | |
Fiscal 2024 Acquisitions | |||
Business Acquisition [Line Items] | |||
Goodwill not expected to be deductible for income tax purposes | $ 17 | ||
Goodwill expected to be deductible for income tax purposes | $ 3.9 | ||
Fiscal 2024 Acquisitions | Customer relationships | |||
Business Acquisition [Line Items] | |||
Estimated useful life (in years) | 10 years | ||
Fiscal 2024 Acquisitions | Tradenames | |||
Business Acquisition [Line Items] | |||
Estimated useful life (in years) | 15 years | ||
Kamco | Forecast | |||
Business Acquisition [Line Items] | |||
Consideration transferred | $ 321.5 |
Business Combinations - Assets
Business Combinations - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | 1 Months Ended | 9 Months Ended | ||
Oct. 31, 2023 | Jan. 31, 2024 | Oct. 01, 2023 | Apr. 30, 2023 | |
Business Acquisition [Line Items] | ||||
Goodwill | $ 723,025 | $ 700,813 | ||
Adjustments, Trade accounts and notes receivable | $ (176) | |||
Adjustments, Goodwill | 3,487 | (132) | ||
Adjustments, Accounts payable and other liabilities | 24 | |||
Adjustments, Deferred income taxes | 1,181 | |||
Adjustments, Fair value of consideration transferred | (501) | |||
Customer relationships | ||||
Business Acquisition [Line Items] | ||||
Adjustments, Finite-lived intangible assets | (4,353) | |||
Tradenames | ||||
Business Acquisition [Line Items] | ||||
Adjustments, Finite-lived intangible assets | $ (664) | |||
Fiscal 2024 Acquisitions | ||||
Business Acquisition [Line Items] | ||||
Cash | 3,027 | $ 3,027 | ||
Trade accounts and notes receivable | 4,426 | 4,602 | ||
Inventories | 8,181 | 8,181 | ||
Other assets | 2,945 | 2,945 | ||
Goodwill | 20,930 | 17,443 | ||
Accounts payable and other liabilities | (3,598) | (3,622) | ||
Deferred income taxes | (5,405) | (6,586) | ||
Fair value of consideration transferred | 59,107 | 59,608 | ||
Fiscal 2024 Acquisitions | Customer relationships | ||||
Business Acquisition [Line Items] | ||||
Finite-lived intangible assets | 23,201 | 27,554 | ||
Fiscal 2024 Acquisitions | Tradenames | ||||
Business Acquisition [Line Items] | ||||
Finite-lived intangible assets | $ 5,400 | $ 6,064 |
Accounts Receivable - Trade Acc
Accounts Receivable - Trade Accounts And Notes Receivable (Details) - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Receivables [Abstract] | ||
Trade receivables | $ 671,201 | $ 713,372 |
Other receivables | 139,068 | 92,496 |
Allowance for expected credit losses | (9,132) | (8,606) |
Other allowances | (6,416) | (5,030) |
Trade accounts and notes receivable | $ 794,721 | $ 792,232 |
Accounts Receivable - Change In
Accounts Receivable - Change In Allowance (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Jan. 31, 2024 | Apr. 30, 2023 | |
Change in allowance | ||
Beginning balance | $ 8,606 | |
Provision | 783 | |
Other, net | (257) | |
Ending balance | 9,132 | |
Receivables from contracts with customers | $ 655,700 | $ 699,700 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Goodwill (Details) - USD ($) $ in Thousands | 1 Months Ended | 9 Months Ended |
Oct. 31, 2023 | Jan. 31, 2024 | |
Goodwill [Roll Forward] | ||
Goodwill gross | $ 765,314 | |
Goodwill, accumulated impairment loss | (64,501) | |
Goodwill balance | 700,813 | |
Goodwill recognized from acquisitions | 20,930 | |
Acquisition accounting adjustments from prior period | $ 3,487 | (132) |
Translation adjustment, gross | 1,907 | |
Translation adjustment, accumulated impairment loss | (493) | |
Translation adjustment, net | 1,414 | |
Goodwill gross | 788,019 | |
Goodwill, accumulated impairment loss | (64,994) | |
Goodwill balance | $ 723,025 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | Apr. 30, 2023 | |
Intangible assets | |||||
Goodwill | $ 723,025 | $ 723,025 | $ 700,813 | ||
Amortization expense | 15,528 | $ 16,257 | 47,193 | $ 50,872 | |
Depreciation and amortization expense | |||||
Intangible assets | |||||
Amortization expense | 15,500 | $ 16,300 | 47,200 | $ 50,900 | |
Geographic divisions | |||||
Intangible assets | |||||
Goodwill | 615,200 | 615,200 | |||
Other | |||||
Intangible assets | |||||
Goodwill | $ 107,800 | $ 107,800 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Definite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Jan. 31, 2024 | Apr. 30, 2023 | |
Intangible assets | ||
Weighted Average Amortization Period | 12 years 8 months 12 days | 12 years 9 months 18 days |
Gross Carrying Amount | $ 803,453 | $ 780,280 |
Accumulated Amortization | (505,206) | (464,987) |
Total | 298,247 | 315,293 |
Indefinite-lived intangible assets | 84,367 | 84,367 |
Total intangible assets, net | $ 382,614 | $ 399,660 |
Customer relationships | ||
Intangible assets | ||
Weighted Average Amortization Period | 12 years 4 months 24 days | 12 years 4 months 24 days |
Gross Carrying Amount | $ 686,471 | $ 669,142 |
Accumulated Amortization | (466,614) | (432,220) |
Total | $ 219,857 | $ 236,922 |
Customer relationships | Minimum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 5 years | 5 years |
Customer relationships | Maximum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 16 years | 16 years |
Definite-lived tradenames | ||
Intangible assets | ||
Weighted Average Amortization Period | 15 years 6 months | 15 years 7 months 6 days |
Gross Carrying Amount | $ 106,118 | $ 100,326 |
Accumulated Amortization | (30,735) | (25,407) |
Total | $ 75,383 | $ 74,919 |
Definite-lived tradenames | Minimum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 5 years | 5 years |
Definite-lived tradenames | Maximum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 20 years | 20 years |
Vendor agreements | ||
Intangible assets | ||
Estimated Useful Lives (years) | 10 years | |
Weighted Average Amortization Period | 10 years | 10 years |
Gross Carrying Amount | $ 1,000 | $ 1,000 |
Accumulated Amortization | (650) | (575) |
Total | $ 350 | $ 425 |
Vendor agreements | Minimum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 8 years | |
Vendor agreements | Maximum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 10 years | |
Developed technology | ||
Intangible assets | ||
Weighted Average Amortization Period | 6 years 10 months 24 days | 6 years 10 months 24 days |
Gross Carrying Amount | $ 8,313 | $ 8,261 |
Accumulated Amortization | (5,882) | (5,596) |
Total | $ 2,431 | $ 2,665 |
Developed technology | Minimum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 5 years | 5 years |
Developed technology | Maximum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 10 years | 10 years |
Other | ||
Intangible assets | ||
Weighted Average Amortization Period | 3 years 2 months 12 days | 3 years 2 months 12 days |
Gross Carrying Amount | $ 1,551 | $ 1,551 |
Accumulated Amortization | (1,325) | (1,189) |
Total | $ 226 | $ 362 |
Other | Minimum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 3 years | 3 years |
Other | Maximum | ||
Intangible assets | ||
Estimated Useful Lives (years) | 5 years | 5 years |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets - Estimated Aggregate Amortization Expense (Details) - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2024 (remaining three months) | $ 14,236 | |
2025 | 53,109 | |
2026 | 44,908 | |
2027 | 38,761 | |
2028 | 32,141 | |
Thereafter | 115,092 | |
Total | $ 298,247 | $ 315,293 |
Long-Term Debt - Components (De
Long-Term Debt - Components (Details) - USD ($) $ in Thousands | Jan. 31, 2024 | May 12, 2023 | Apr. 30, 2023 |
Long-term debt | |||
Long-term debt, gross | $ 1,040,480 | ||
Finance lease obligations | 158,437 | $ 137,303 | |
Carrying value of debt | 1,030,761 | 1,098,677 | |
Less current portion | 48,094 | 54,035 | |
Long-term debt | 982,667 | 1,044,642 | |
Term Loan Facility | |||
Long-term debt | |||
Long-term debt, gross | 498,750 | $ 499,500 | 499,503 |
Unamortized discount and deferred financing costs | (6,106) | (2,442) | |
Senior Notes | |||
Long-term debt | |||
Long-term debt, gross | 350,000 | 350,000 | |
Unamortized discount and deferred financing costs | $ (3,596) | (4,113) | |
Interest rate | 4.625% | ||
ABL Facility | |||
Long-term debt | |||
Long-term debt, gross | $ 29,000 | 110,000 | |
Installment Notes | |||
Long-term debt | |||
Long-term debt, gross | 4,293 | 8,529 | |
Unamortized discount | $ (17) | $ (103) | |
Interest rate | 5% |
Long-Term Debt - Narrative (Det
Long-Term Debt - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Feb. 02, 2024 | Feb. 01, 2024 | May 12, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | Apr. 30, 2023 | |
Long-term debt | ||||||||
Long-term debt, gross | $ 1,040,480 | $ 1,040,480 | ||||||
Borrowings from term loan amendment | 288,266 | $ 0 | ||||||
Repayments from term loan amendment | 287,769 | 0 | ||||||
Write-off of debt discount and deferred financing fees | $ 0 | $ 0 | 1,401 | $ 0 | ||||
Term Loan Facility | ||||||||
Long-term debt | ||||||||
Loan quarterly payments | $ 1,300 | |||||||
Loan quarterly payments of the principal amount (as a percent) | 0.25% | |||||||
Borrowing interest rate (as a percent) | 8.33% | 8.33% | ||||||
Long-term debt, gross | $ 499,500 | $ 498,750 | $ 498,750 | $ 499,503 | ||||
Term Loan Facility | SOFR | Subsequent Event | ||||||||
Long-term debt | ||||||||
Margin added to variable rate (as a percent) | 2.25% | 3% | ||||||
Term Loan Facility, Due 2030 | ||||||||
Long-term debt | ||||||||
Principal amount | 500,000 | |||||||
Increase in aggregate principal amount | 500 | |||||||
Cashless roll | 211,700 | |||||||
Borrowings from term loan amendment | 288,300 | |||||||
Repayments from term loan amendment | $ 287,800 | |||||||
Maturity date extension term | 7 years | |||||||
Amendment To Term Loan Facility | ||||||||
Long-term debt | ||||||||
Write-off of debt discount and deferred financing fees | 1,400 | |||||||
Senior Notes | ||||||||
Long-term debt | ||||||||
Long-term debt, gross | $ 350,000 | $ 350,000 | $ 350,000 | |||||
Interest rate | 4.625% | 4.625% | ||||||
Amended ABL Facility | ||||||||
Long-term debt | ||||||||
Borrowing weighted average interest rate (as a percent) | 8.75% | 8.75% | ||||||
Available borrowing capacity under the facility | $ 813,400 | $ 813,400 | ||||||
Amended ABL Facility | Revolving Credit Facility | ||||||||
Long-term debt | ||||||||
Maximum amount under the facility | $ 950,000 | $ 950,000 |
Long-Term Debt - Maturities (De
Long-Term Debt - Maturities (Details) - USD ($) $ in Thousands | Jan. 31, 2024 | May 12, 2023 | Apr. 30, 2023 |
Long-term debt | |||
2024 (remaining three months) | $ 12,427 | ||
2025 | 48,164 | ||
2026 | 41,456 | ||
2027 | 35,914 | ||
2028 | 58,029 | ||
Thereafter | 844,490 | ||
Total | 1,040,480 | ||
Term Loan Facility | |||
Long-term debt | |||
2024 (remaining three months) | 1,250 | ||
2025 | 5,000 | ||
2026 | 5,000 | ||
2027 | 5,000 | ||
2028 | 5,000 | ||
Thereafter | 477,500 | ||
Total | 498,750 | $ 499,500 | $ 499,503 |
Senior Notes | |||
Long-term debt | |||
2024 (remaining three months) | 0 | ||
2025 | 0 | ||
2026 | 0 | ||
2027 | 0 | ||
2028 | 0 | ||
Thereafter | 350,000 | ||
Total | 350,000 | 350,000 | |
ABL Facility | |||
Long-term debt | |||
2024 (remaining three months) | 0 | ||
2025 | 0 | ||
2026 | 0 | ||
2027 | 0 | ||
2028 | 29,000 | ||
Thereafter | 0 | ||
Total | 29,000 | 110,000 | |
Finance Leases | |||
Long-term debt | |||
2024 (remaining three months) | 11,103 | ||
2025 | 41,549 | ||
2026 | 35,742 | ||
2027 | 30,220 | ||
2028 | 23,409 | ||
Thereafter | 16,414 | ||
Total | 158,437 | ||
Installment Notes | |||
Long-term debt | |||
2024 (remaining three months) | 74 | ||
2025 | 1,615 | ||
2026 | 714 | ||
2027 | 694 | ||
2028 | 620 | ||
Thereafter | 576 | ||
Total | $ 4,293 | $ 8,529 |
Leases - Components of Lease Ex
Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | |
Finance lease cost: | ||||
Amortization of right-of-use assets | $ 7,419 | $ 6,121 | $ 21,297 | $ 17,918 |
Interest on lease liabilities | 2,072 | 1,800 | 5,826 | 5,361 |
Operating lease cost | 16,231 | 13,293 | 47,980 | 39,272 |
Variable lease cost | 4,155 | 4,919 | 12,594 | 16,499 |
Total lease cost | $ 29,877 | $ 26,133 | $ 87,697 | $ 79,050 |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Jan. 31, 2024 | Jan. 31, 2023 | |
Cash paid for amounts included in the measurement of lease liabilities | ||
Operating cash flows from operating leases | $ 46,835 | $ 39,675 |
Operating cash flows from finance leases | 5,826 | 5,361 |
Financing cash flows from finance leases | 30,381 | 26,167 |
Right-of-use assets obtained in exchange for lease obligations | ||
Operating leases | 39,865 | 34,607 |
Finance leases | $ 55,662 | $ 42,421 |
Leases - Other Information (Det
Leases - Other Information (Details) - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Finance leases included in property and equipment | ||
Property and equipment | $ 269,168 | $ 231,488 |
Accumulated depreciation | (71,529) | (65,274) |
Property and equipment, net | $ 197,639 | $ 166,214 |
Finance lease, right-of-use asset, balance sheet location [Extensible List] | Property and equipment, net of accumulated depreciation of $295,789 and $264,650, respectively | Property and equipment, net of accumulated depreciation of $295,789 and $264,650, respectively |
Weighted-average remaining lease term (years) | ||
Operating leases | 5 years 3 months 18 days | 5 years 2 months 12 days |
Finance leases | 4 years | 3 years 10 months 24 days |
Weighted-average discount rate | ||
Operating leases | 5.60% | 5% |
Finance leases | 5.50% | 4.90% |
Leases - Future Minimum Lease P
Leases - Future Minimum Lease Payments Under Non-Cancellable Leases (Details) - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Finance | ||
2024 (remaining three months) | $ 13,149 | |
2025 | 48,416 | |
2026 | 40,708 | |
2027 | 33,504 | |
2028 | 25,196 | |
Thereafter | 17,140 | |
Total lease payments | 178,113 | |
Less imputed interest | 19,676 | |
Total | 158,437 | $ 137,303 |
Operating | ||
2024 (remaining three months) | 12,390 | |
2025 | 57,863 | |
2026 | 45,063 | |
2027 | 33,420 | |
2028 | 23,704 | |
Thereafter | 54,334 | |
Total lease payments | 226,774 | |
Less imputed interest | 32,731 | |
Total | $ 194,043 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) | 9 Months Ended | ||
Jan. 31, 2024 | Jan. 31, 2023 | Apr. 30, 2023 | |
Income Tax Disclosure [Abstract] | |||
Effective income tax rate (as a percent) | 24.50% | 26.30% | |
Valuation allowance | $ 11,800,000 | $ 11,700,000 | |
Reserve for uncertain tax positions | $ 0 | $ 0 |
Stockholders' Equity - Narrativ
Stockholders' Equity - Narrative (Details) - USD ($) | 9 Months Ended | ||
Jan. 31, 2024 | Oct. 18, 2023 | Oct. 17, 2023 | |
Equity [Abstract] | |||
Stock repurchase program, authorized amount | $ 250,000,000 | $ 200,000,000 | |
Remaining amount under repurchase program | $ 216,500,000 | ||
Other comprehensive income (loss) on derivative instruments before reclassification, tax | 1,500,000 | ||
Reclassification to earnings from accumulated other comprehensive income (loss) on derivative instruments, tax | 700,000 | ||
Gain (loss) on intra-entity transactions, long-term investment, tax | $ 1,200,000 |
Stockholders' Equity - Share Re
Stockholders' Equity - Share Repurchase Activity (Details) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Jan. 31, 2024 | Oct. 31, 2023 | Jul. 31, 2023 | Jan. 31, 2023 | Oct. 31, 2022 | Jul. 31, 2022 | Jan. 31, 2024 | Jan. 31, 2023 | |
Equity [Abstract] | ||||||||
Amount repurchased pursuant to repurchase program | $ 99,609 | $ 82,767 | ||||||
Excise taxes on repurchases | 683 | |||||||
Repurchases of common stock | $ 24,936 | $ 44,572 | $ 30,784 | $ 33,196 | $ 25,776 | $ 23,795 | $ 100,292 | $ 82,767 |
Number of share repurchased (in shares) | 1,528 | 1,773 |
Stockholders' Equity - Accumula
Stockholders' Equity - Accumulated Other Comprehensive Loss (Details) $ in Thousands | 9 Months Ended |
Jan. 31, 2024 USD ($) | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | $ 1,274,757 |
Other comprehensive income (loss) before reclassification | 1,918 |
Gains on intra-entity transactions that are of a long-term investment nature | 7,363 |
Reclassification to earnings from accumulated other comprehensive loss | (2,084) |
Ending balance | 1,418,944 |
Accumulated Other Comprehensive Loss | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | (35,129) |
Ending balance | (27,932) |
Foreign Currency Translation | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | (35,129) |
Other comprehensive income (loss) before reclassification | (2,725) |
Gains on intra-entity transactions that are of a long-term investment nature | 7,363 |
Reclassification to earnings from accumulated other comprehensive loss | 0 |
Ending balance | (30,491) |
Derivative Financial Instruments | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | 0 |
Other comprehensive income (loss) before reclassification | 4,643 |
Gains on intra-entity transactions that are of a long-term investment nature | 0 |
Reclassification to earnings from accumulated other comprehensive loss | (2,084) |
Ending balance | $ 2,559 |
Equity-Based Compensation - Nar
Equity-Based Compensation - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation expense | $ 3,559 | $ 3,285 | $ 11,974 | $ 10,198 |
Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Intrinsic value of options exercised | 12,400 | 6,500 | ||
Unrecognized compensation cost, options | 6,700 | $ 6,700 | ||
Weighted-average period for recognition of unrecognized compensation expense (in years) | 1 year 9 months 18 days | |||
Restricted stock units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Weighted-average period for recognition of unrecognized compensation expense (in years) | 1 year 6 months | |||
Fair value of awards vested | $ 13,000 | 8,800 | ||
Unrecognized compensation cost, RSUs | $ 9,500 | 9,500 | ||
ESPP | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation expense | $ 1,000 | 800 | ||
Percentage of common stock price based on closing price at the beginning or end of the last day of the purchase period | 90% | |||
Purchase period (in months) | 6 months | |||
Selling, general and administrative expenses | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation expense | $ 11,000 | $ 9,400 |
Equity-Based Compensation - Sto
Equity-Based Compensation - Stock Option Activity (Details) - Stock Options $ / shares in Units, shares in Thousands, $ in Thousands | 9 Months Ended | 12 Months Ended |
Jan. 31, 2024 USD ($) $ / shares shares | Apr. 30, 2023 USD ($) $ / shares shares | |
Number of Options | ||
Outstanding, beginning of the period (in shares) | shares | 1,106 | |
Options granted (in shares) | shares | 151 | |
Options exercised (in shares) | shares | (228) | |
Options forfeited (in shares) | shares | (13) | |
Outstanding, end of the period (in shares) | shares | 1,016 | 1,106 |
Exercisable at end of period (in shares) | shares | 680 | |
Vested and expected to vest at end of period (in shares) | shares | 1,015 | |
Weighted Average Exercise Price | ||
Outstanding, beginning of period (in dollars per share) | $ / shares | $ 32.60 | |
Options granted (in dollars per share) | $ / shares | 74.75 | |
Options exercised (in dollars per share) | $ / shares | 22.12 | |
Options forfeited (in dollars per share) | $ / shares | 42.11 | |
Outstanding, end of the period (in dollars per share) | $ / shares | 41.11 | $ 32.60 |
Exercisable at end of period (in dollars per share) | $ / shares | 30.63 | |
Vested and expected to vest at end of period (in dollars per share) | $ / shares | $ 41.11 | |
Other disclosures | ||
Weighted Average Remaining Contractual Life, Outstanding (in years) | 6 years 9 months 18 days | 6 years 6 months |
Weighted Average Remaining Contractual Life, Exercisable at end of period (in years) | 5 years 9 months 18 days | |
Weighted Average Remaining Contractual Life, Vested and expected to vest at end of period (in years) | 6 years 9 months 18 days | |
Aggregate Intrinsic Value, Outstanding | $ | $ 43,710 | $ 28,155 |
Aggregate Intrinsic Value, Exercisable at end of period | $ | 36,409 | |
Aggregate Intrinsic Value, Vested and expected to vest at end of period | $ | $ 43,701 |
Equity-Based Compensation - Bla
Equity-Based Compensation - Black Scholes Options - Pricing Model (Details) - Stock Options - $ / shares | 9 Months Ended | |
Jan. 31, 2024 | Jan. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Volatility (as a percent) | 38.70% | 45.80% |
Expected life (years) | 6 years | 6 years |
Risk-free interest rate (as a percent) | 4.29% | 2.67% |
Dividend yield (as a percent) | 0% | 0% |
Grant date fair value (in dollars per share) | $ 33.33 | $ 25.26 |
Equity-Based Compensation - Res
Equity-Based Compensation - Restricted Stock Units (Details) - Restricted stock units shares in Thousands | 9 Months Ended |
Jan. 31, 2024 $ / shares shares | |
Number of Restricted Stock Units | |
Outstanding, beginning of the period (in shares) | shares | 353 |
Granted (in shares) | shares | 141 |
Vested (in shares) | shares | (175) |
Forfeited (in shares) | shares | (5) |
Outstanding, end of the period (in shares) | shares | 314 |
Weighted Average Grant Date Fair Value | |
Outstanding, beginning of period (in dollars per share) | $ / shares | $ 46.97 |
Granted (in dollars per share) | $ / shares | 74.80 |
Vested (in dollars per share) | $ / shares | 44.52 |
Forfeited (in dollars per share) | $ / shares | 52.39 |
Outstanding, end of the period (in dollars per share) | $ / shares | $ 60.74 |
Equity-Based Compensation - Emp
Equity-Based Compensation - Employee Stock Purchase Plan (Details) - ESPP - $ / shares shares in Thousands | 9 Months Ended | |
Jan. 31, 2024 | Jan. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of shares purchased under ESPP (in shares) | 89 | 79 |
Average price per share (in dollars per share) | $ 51.74 | $ 40.47 |
Stock Appreciation Rights, De_3
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests (Details) - USD ($) $ in Thousands | 9 Months Ended | ||
Jan. 31, 2024 | Jan. 31, 2023 | Apr. 30, 2023 | |
Selling, general and administrative expenses | |||
Deferred Compensation Liability, Current and Noncurrent [Roll Forward] | |||
Expense related to equity based compensation arrangements | $ 4,500 | $ 7,100 | |
Stock Appreciation Rights | |||
Deferred Compensation Liability, Current and Noncurrent [Roll Forward] | |||
Award liability as of beginning of period | 32,432 | ||
Amounts redeemed | (1,810) | ||
Change in fair value | 3,408 | ||
Award liability as of end of period | 34,030 | ||
Current liabilities related to plans | 8,123 | $ 7,446 | |
Long-term liabilities related to plans | 25,907 | 24,986 | |
Deferred Compensation | |||
Deferred Compensation Liability, Current and Noncurrent [Roll Forward] | |||
Award liability as of beginning of period | 2,407 | ||
Amounts redeemed | (586) | ||
Change in fair value | 160 | ||
Award liability as of end of period | 1,981 | ||
Current liabilities related to plans | 684 | 545 | |
Long-term liabilities related to plans | 1,297 | 1,862 | |
Redeemable Noncontrolling Interests | |||
Deferred Compensation Liability, Current and Noncurrent [Roll Forward] | |||
Award liability as of beginning of period | 12,002 | ||
Amounts redeemed | (2,931) | ||
Change in fair value | 965 | ||
Award liability as of end of period | 10,036 | ||
Current liabilities related to plans | 3,423 | 2,726 | |
Long-term liabilities related to plans | $ 6,613 | $ 9,276 |
Fair Value Measurements - Fair
Fair Value Measurements - Fair Value of Derivative Liabilities (Details) - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Interest rate swaps and collars | Level 2 | Fair Value, Measurements, Recurring | ||
Fair Value Measurements | ||
Derivative liabilities | $ 3,390 | $ 0 |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions | 1 Months Ended | 3 Months Ended | 9 Months Ended |
May 31, 2023 | Jan. 31, 2024 | Jan. 31, 2024 | |
Interest rate swap agreements | |||
Fair Value Measurements | |||
Change in fair value of financial instruments | $ 0.8 | $ 2.1 | |
Expected earnings to be reclassified during next twelve months | 2.2 | 2.2 | |
Interest rate swap agreements | Prepaid expenses and other current assets | |||
Fair Value Measurements | |||
Derivative liabilities | 2.2 | 2.2 | |
Interest rate swap agreements | Other assets | |||
Fair Value Measurements | |||
Derivative liabilities | $ 1.2 | $ 1.2 | |
Interest rate swap agreements | Term Loan Facility, Due 2030 | |||
Fair Value Measurements | |||
Derivative term | 2 years | ||
Notional amount | $ 300 | ||
Interest rate swap agreements | Term Loan Facility, Due 2030 | SOFR | |||
Fair Value Measurements | |||
Fixed interest rate | 3.899% | ||
Forward interest rate collar | Term Loan Facility, Due 2030 | |||
Fair Value Measurements | |||
Notional amount | $ 300 |
Fair Value Measurements - Fai_2
Fair Value Measurements - Fair Value of Debt (Details) - Level 2 - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Carrying Amount | ||
Fair Value Measurements | ||
Senior Notes | $ 350,000 | $ 350,000 |
Fair Value | ||
Fair Value Measurements | ||
Senior Notes | $ 324,188 | $ 308,000 |
Segments - Net Sales, Adjusted
Segments - Net Sales, Adjusted EBITDA and Certain Other Measures (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | |
Segment information | ||||
Net sales | $ 1,258,348 | $ 1,234,618 | $ 4,088,878 | $ 4,025,150 |
Gross Profit | 414,720 | 402,248 | 1,323,903 | 1,301,469 |
Depreciation and Amortization | 32,804 | 31,419 | 97,759 | 96,085 |
Adjusted EBITDA | 128,020 | 140,828 | 468,876 | 511,355 |
Geographic divisions | ||||
Segment information | ||||
Net sales | 1,224,907 | 1,201,183 | 3,992,941 | 3,928,170 |
Gross Profit | 399,000 | 384,093 | 1,272,880 | 1,244,099 |
Depreciation and Amortization | 29,179 | 27,159 | 86,289 | 82,887 |
Adjusted EBITDA | 124,911 | 133,792 | 454,503 | 486,968 |
Other | ||||
Segment information | ||||
Net sales | 33,441 | 33,435 | 95,937 | 96,980 |
Gross Profit | 15,720 | 18,155 | 51,023 | 57,370 |
Depreciation and Amortization | 3,544 | 4,140 | 11,217 | 12,827 |
Adjusted EBITDA | 3,109 | 7,036 | 14,373 | 24,387 |
Corporate | ||||
Segment information | ||||
Net sales | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 |
Depreciation and Amortization | 81 | 120 | 253 | 371 |
Adjusted EBITDA | $ 0 | $ 0 | $ 0 | $ 0 |
Segments - Reconciliation of Ne
Segments - Reconciliation of Net Income to Adjusted EBITDA (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Jan. 31, 2024 | Oct. 31, 2023 | Jul. 31, 2023 | Jan. 31, 2023 | Oct. 31, 2022 | Jul. 31, 2022 | Jan. 31, 2024 | Jan. 31, 2023 | |
Segment Reporting [Abstract] | ||||||||
Net income | $ 51,905 | $ 80,957 | $ 86,830 | $ 64,775 | $ 103,153 | $ 89,470 | $ 219,692 | $ 257,398 |
Interest expense | 18,784 | 16,943 | 56,440 | 47,659 | ||||
Write-off of debt discount and deferred financing fees | 0 | 0 | 1,401 | 0 | ||||
Interest income | (378) | (180) | (1,144) | (390) | ||||
Provision for income taxes | 17,468 | 23,697 | 71,407 | 91,722 | ||||
Depreciation expense | 17,276 | 15,162 | 50,566 | 45,213 | ||||
Amortization expense | 15,528 | 16,257 | 47,193 | 50,872 | ||||
Stock appreciation rights | 1,789 | 314 | 3,408 | 5,888 | ||||
Redeemable noncontrolling interests and deferred compensation | 461 | 368 | 1,125 | 1,203 | ||||
Equity-based compensation | 3,559 | 3,285 | 11,974 | 10,198 | ||||
Severance and other permitted costs | 1,033 | (315) | 2,321 | 416 | ||||
Transaction costs (acquisitions and other) | 765 | 476 | 3,373 | 1,154 | ||||
(Gain) loss on disposal of assets | (222) | (411) | (663) | (614) | ||||
Effects of fair value adjustments to inventory | 8 | 457 | 450 | 636 | ||||
Debt transaction costs | 44 | 0 | 1,333 | 0 | ||||
Adjusted EBITDA | $ 128,020 | $ 140,828 | $ 468,876 | $ 511,355 |
Segments - Net Sales by Main Pr
Segments - Net Sales by Main Product Lines (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | |
Revenue from external customers | ||||
Total net sales | $ 1,258,348 | $ 1,234,618 | $ 4,088,878 | $ 4,025,150 |
Wallboard | ||||
Revenue from external customers | ||||
Total net sales | 520,686 | 500,710 | 1,677,285 | 1,606,821 |
Complementary products | ||||
Revenue from external customers | ||||
Total net sales | 378,555 | 352,647 | 1,233,084 | 1,157,144 |
Steel framing | ||||
Revenue from external customers | ||||
Total net sales | 203,363 | 234,451 | 672,231 | 787,499 |
Ceilings | ||||
Revenue from external customers | ||||
Total net sales | $ 155,744 | $ 146,810 | $ 506,278 | $ 473,686 |
Segments - Net Sales by Major G
Segments - Net Sales by Major Geographic Area (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2024 | Jan. 31, 2023 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Total net sales | $ 1,258,348 | $ 1,234,618 | $ 4,088,878 | $ 4,025,150 |
United States | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Total net sales | 1,107,244 | 1,089,888 | 3,564,530 | 3,530,083 |
Canada | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Total net sales | $ 151,104 | $ 144,730 | $ 524,348 | $ 495,067 |
Segments - Property and Equipme
Segments - Property and Equipment, Net, By Major Geographic Area (Details) - USD ($) $ in Thousands | Jan. 31, 2024 | Apr. 30, 2023 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total property and equipment, net | $ 437,386 | $ 396,419 |
United States | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total property and equipment, net | 390,788 | 354,652 |
Canada | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total property and equipment, net | $ 46,598 | $ 41,767 |
Earnings Per Common Share (Deta
Earnings Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Jan. 31, 2024 | Oct. 31, 2023 | Jul. 31, 2023 | Jan. 31, 2023 | Oct. 31, 2022 | Jul. 31, 2022 | Jan. 31, 2024 | Jan. 31, 2023 | |
Computation of basic and diluted earnings per share of common stock | ||||||||
Net income | $ 51,905 | $ 80,957 | $ 86,830 | $ 64,775 | $ 103,153 | $ 89,470 | $ 219,692 | $ 257,398 |
Basic earnings per common share: | ||||||||
Basic weighted average common shares outstanding (in shares) | 39,864 | 41,578 | 40,360 | 42,119 | ||||
Basic earnings per common share (in dollars per share) | $ 1.30 | $ 1.56 | $ 5.44 | $ 6.11 | ||||
Diluted earnings per common share: | ||||||||
Basic weighted average common shares outstanding (in shares) | 39,864 | 41,578 | 40,360 | 42,119 | ||||
Add: Common Stock Equivalents (in shares) | 648 | 654 | 666 | 693 | ||||
Diluted weighted average common shares outstanding (in shares) | 40,512 | 42,232 | 41,026 | 42,812 | ||||
Diluted earnings per common share (in dollars per share) | $ 1.28 | $ 1.53 | $ 5.35 | $ 6.01 | ||||
Shares were not included in the calculation of Diluted loss per common share | ||||||||
Anti-dilutive shares (in shares) | 0 | 0 | 0 | 0 |
Subsequent Event (Details)
Subsequent Event (Details) - Subsequent Event - Term Loan Facility | Feb. 02, 2024 | Feb. 01, 2024 |
SOFR | ||
Subsequent Events | ||
Margin added to variable rate (as a percent) | 2.25% | 3% |
Base Rate | ||
Subsequent Events | ||
Margin added to variable rate (as a percent) | 1.25% | 2% |